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 Huntington’s disease is neurodegenerative disease caused by an expanded 
polyglutamine-coding CAG repeat in exon 1 of the huntingtin gene. Huntingtin exon 1 
forms the primary toxic amyloid structure in Huntington’s disease; disease severity is 
directly correlated with polyglutamine length. Recent works have shown that fully 
formed amyloid plaques may not represent the most toxic species in Huntington’s 
disease; the most neurotoxic species may be small, diffuse oligomer (4 – 20 monomer 
units) that are precursors to amyloid plaques. While the polyglutamine region is 
undisputed as the primary constituent of amyloid structure, aggregation kinetics and 
morphology are regulated by the presence of flanking sequences that are N- and C-
terminal to theamyloid forming tract. The first seventeen residues of huntingtin exon 1 
(Nt17) can form an amphipathic α-helix depending upon solution conditions and the 
presence of a binding partner, and in most cases, mediates oligomer formation. C-
terminal to the polyglutamine tract is a proline-rich region, or in the case of a model 
peptide a polyproline region (polyP), that can form a polyproline-type II (PPII) helix, 
which may regulate Nt17 in huntingtin protein with short polyglutamine regions. Much is 
unknown regarding residue-specific Nt17-Nt17 and Nt17-polyP interactions. The work 
described here utilized state-of-the-art deuterium exchange mass spectrometry 
techniques to identify critical hydrophilic residues in early stages of oligomer formation. 




domain, were then studied using ion mobility-mass spectrometry and molecular 
dynamics to gain insight into the earliest stages of Nt17-Nt17 association, and thus, 
aggregation. Monomeric and multimeric Nt17 could form extended helices in the gas 
phase. Key hydrophilic residues were chemically modified, which resulted in a sharp 
decline in multimer formation. Finally, Nt17-polyP interactions were probed using gas-
phase deuterium exchange mass spectrometry, supplemented with molecular dynamics 
and an exchange kinetics model. The obtained gas-phase structures showed a 
reduction in Nt17 extended α-helix, when compared to a monomeric and extended 
homodimeric conformation. Thus, it is hypothesized that polyP regulates Nt17 by not 
allowing transition to the amphipathic α-helix. The results of this study examine the 
structural heterogeneity of a sequence thought to drive a potentially toxic aggregate 
morphology, pinpoint key residues in early oligomer formation, and provide strategies 









































“No problem that is describable is unsolvable.” 
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1. Introduction: Insights to neurodegenerative disease provided 
by deuterium exchange and ion mobility-mass spectrometry1 
1Reproduced in part with permission from BioMolecular Concepts: The emerging role of 
the first 17 amino acids of huntingtin in Huntington’s disease. Arndt, J. R., Chaibva, M., 
and Legleiter, J. BioMolecular Concepts 6, 2015, 33–46. 
  
1.1 Huntington’s disease oligomerization is facilitated by the presence of 
flanking sequences. 
 Huntington’s disease (HD) is a fatal neurodegenerative disease caused by 
an expanded polyglutamine- (polyQ) coding CAG repeat domain in exon 1 the 
huntingtin gene (HTT).1 The expanded polyQ domain in the resulting huntingtin 
protein (htt) forms amyloid fibrils and inclusion bodies in vivo, leading to distinct 
symptoms of neurodegeneration, such as chorea, fatigue, changes in 
personality, loss of motor function, and eventually, death.2 Disease length 
threshold for the polyQ repeat is approximately 35 residues; disease severity is 
directly correlated to polyQ length, while age of onset is inversely correlated.3 
Currently, there is no cure for HD.  
 Recent research efforts have been focused on structural characterization 
of in vitro polyQ fibril structure;4-7 however, fibrils may represent a 
neuroprotective species. Formation of inclusion bodies can be a predictor of cell 
survival.8 Oligomers, small soluble aggregates composed of four to twenty 
monomer units, could represent the most toxic species in HD. In the same study 
that showed prediction of cell survival as a function of inclusion body formation, 
the presence of diffuse oligomeric species almost always led to neuronal death.8 
Htt oligomers have been observed by time-dependent electron microscopy in 
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human HD brains exhibiting a phenotype for disease.9 Flanking sequences that 
surround the polyQ domain drive htt oligomerization. C-terminal to the polyQ tract 
is a proline-rich domain that contains a PPII helix (Figure 1.1). This tract supports 
anchoring and subsequent aggregation on lipid substrates.10 
 
Figure 1.1. Schematic representation of various features of the huntingtin (htt) 
protein. (A) Full-length htt with HEAT repeat sites (dark gray). Exon 1 is denoted by the 
black box. (B) Primary sequence of htt exon 1 indicating Nt17 (green), polyglutamine 
(polyQ) (purple), and the proline-rich region (gray). (C) Theoretical three-dimensional 
structure of Nt17 indicating hydrophilic (red) and hydrophobic (blue) faces of an 
amphipathic α -helix. (D) View down the barrel of the α -helix showing relative 
hydrophobicity of each residue (same color scheme as panel C), as well as the sites of 
reported posttranslational modification. Reproduced from BioMolecular Concepts: The 
emerging role of the first 17 amino acids of huntingtin in Huntington’s disease. Arndt, J. 
R., Chaibva, M., and Legleiter, J. BioMolecular Concepts 6, 2015, 33–46. 
 
N-terminal to the polyQ region is a seventeen-residue tract (Nt17) that can form 
an amphipathic α-helix once incorporated into an amyloid fibril.4, 11 This domain is 
thought to be required for htt oligomer formation both in solution12 and on a lipid 
substrate.10 Since Nt17 presents a potential driving force behind the formation of 
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the most toxic aggregate species, it represents a potential target for therapeutic 
remediation of HD. Thus, a thorough understanding of the nature of amphipathic 
α-helices and interactions of Nt17 is vital. 
 
1.2 The Nt17 amphipathic α-helix. 
  An amphipathic α-helix consists of a typical α-helix whose faces are 
separated into a hydrophobic and hydrophilic domain (Figure 1.1C). This 
arrangement is suitable for hydrophobic interaction with other helices in an 
aqueous cellular environment,13, 14 as well as lipid membrane binding.15, 16 
Amphipathic helices preferentially bind to sites of membrane curvature and can 
be used as sensors of curved membranes.17 Nt17 has been shown to sequester 
truncated htt exon 1 peptides to regions of curvature on supported lipid 
bilayers.18 The Nt17 primary sequence contains three basic lysine residues at 
positions 6, 9, and 15. Residues 6 and 9 lie on the boundary of the hydrophilic 
and hydrophobic faces in a theoretical full helix (Figure 1.1C and D). Additionally, 
two methionine, two serine, and two glutamic acid residues are encompassed in 
the hydrophilic face. The hydrophobic face consists of two phenylalanine 
residues, three leucine residues, and an alanine residue, with a leucine and a 
phenylalanine at each side of the boundary. It would appear that residues in the 
boundary region are critical in lipid membrane binding and intermolecular 
interaction. Simulation of lipid membrane association shows K6 and K15 are 
strong hydrogen bond donors with lipid bilayers.19 These studies point to critical 
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interactions involving amphipathic helices that can potentially modulate toxicity 
and aggregation kinetics. 
 While there is little doubt Nt17 forms an amphipathic helix, whether the 
monomeric form of Nt17 is helical, either by itself or attached to the polyQ 
domain, has been the topic of much discussion. The first crystal structure of htt 
exon 1 showed that Nt17 is fully helical, with the helix extending into the polyQ 
domain.20 Atomistic simulation in explicit aqueous solvent, circular dichroism 
spectropolarimetry (CD) and solution NMR also point to transient helical 
properties in the monomeric form.21-24 Separate analytical untracentrifugation 
(AUC) and CD studies have shown that Nt17 alone is only transiently helical, and 
only forms the full, stable amphipathic helix upon association with a binding 
partner.12 Jayaraman et al. determined by the methods listed above (AUC and 
CD) that mostly random coil monomeric Nt17 exists in solution in equilibrium with 
an α-helix rich tetrameric species that can nucleate amyloid formation.12 The 
experiment used Nt17 with short polyQ segments to model the early stages of 
amyloid formation. The AUC experiment showed the propensity for Nt17 to 
tetramerize, while concentration-dependent CD showed an increase in α-helicity 
for isolated Nt17 aggregates.12 Combined, these peptide experiments provide 
quaternary arrangement and associated secondary structure. Those that did not 
tetramerize are hypothesized to serve as a pool from which monomer addition 
can occur. Solid state NMR and FTIR studies confirm that the Nt17 α-helix is 
conserved upon aggregation with polyQ segments above n = 30.11 The FTIR 
experiments showed a strong IR absorbance at 1655 cm-1, indicative of α-helical 
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character, from both small aggregates of Nt17 as well as htt exon 1 model 
peptides. Additionally, ssNMR chemical shifts indicate residues 4 – 11 are in an 
α-helical arrangement, while residues 17 – 19 have a clear β-sheet structure.11 
The disordered monomeric structures reported by Jayaraman et al. are in 
contrast to other studies that state Nt17 is mostly helical in solution. Kelley, et al. 
show from atomistic simulation that Nt17 exists in a two-helix bundle at 300K and 
transiently exists as a straight helix.17, 24 Their study shows Nt17 tends toward a 
more globular state at temperatures exceeding 400K. Their findings could 
corroborate the structural heterogeneity reported in the AUC and CD studies, 
though, with regard to secondary structure, they are in disagreement. Still, 
compelling evidence suggests the α-helix is conserved in the aggregated form 
and located on the periphery of the amyloid structure,5, 11 which can have 
significant ramifications in aggregation mechanism.  
 
1.3 Nt17 in the oligomerization pathway. 
 Nt17 has been implicated in driving the initial phases of htt exon 1 
interaction.11, 25-28 As such, several mechanisms exist that are mediated by Nt17. 
Most agree that the initial phase of aggregation begins with interaction of Nt17, 
which forms a population of small, α-helix rich oligomers 23, 29, 30 that are widely 
considered to be the toxic species in Huntington’s disease9, 31 and this represents 
the rate-limiting step in htt exon 1 aggregation.12, 32 That is, in a cellular 
environment, pathogenic htt exon 1 oligomer population did not appreciably 
change despite recruitment of moomers into inclusion bodies, hence, the 
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formation of oligomeric species is the rate-determining step in one aggregation 
pathway, most likely one that is mediated by Nt17.32 PolyQ peptides that do not 
have the N-terminal flanking sequence do not form oligomeric intermediates and 
as a result, proceed directly to fibrillar aggregates.12, 26 The mechanism for Nt17 
mediated htt exon 1 aggregation begins with an association between monomeric 
htt exon 1 that is rich in α-helix structure. As stated, this helicity may be a result 
of,12, 26, 33 or preclude,22, 24 association. These helical bundles represent the 
potentially toxic oligomer structure, wherein the polyQ domain is still 
disordered.12, 26 The oligomerization process is spontaneous and reversible, with 
multimer dissociation occurring when polyQ β-sheet nucleation does not occur, 
thus replenishing the monomer pool.12, 26, 33 The helical bundle structure places 
the pathogenic polyQ tract in favorable proximity to form increased β-sheet 
structure.11, 12, 26, 33 The fibril increases in size by monomer addition, forming 
elongated β-sheet rich amyloid fibrils. The fate of Nt17 appears to be on the 
periphery of the amyloid structure, as shown by deuterium exchange ssNMR11; 
however, pre-aggregated htt exon 1 does not bind to lipid membranes, which 
suggests Nt17 is tightly bound, or otherwise unavailable, in the final amyloid 
structure.34 Other mechanisms of htt exon 1 aggregation suggest that amyloid 
formation is a result of misfolded polyQ β-hairpin turn that leads to nucleation; in 
their study, Kar et al. show that an induced β-turn in polyglutamine repeats, by 
addition of a Pro – Gly sequence,  can induce amyloid formation similar to htt 
exon 1.35 These structures do not, however, contain the Nt17 tract and represent 
a mechanism of fibril formation that is not mediated by Nt17, but which does 
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explain the polyQ length dependence on aggregation: longer polyQ lengths can 
experience more structural freedom and are more likely to form a nucleation-
enhancing β-turn.35, 36  These two mechanisms, while at face value are 
mechanistically dissimilar, may combine to provide a clearer picture of htt exon 1 
aggregation.9 Variant monomeric structures could lead to the formation of 
inclusion bodies or annular aggregates.9  Monomers can misfold, e.g., formation 
of a β-hairpin in monomers with pathogenic polyQ length, and proceed directly to 
fibrillar aggregates, eventually maturing into inclusion bodies, entirely bypassing 
the oligomeric intermediate state. Alternatively, Nt17-mediated nucleation occurs 
via the oligomeric intermediate, which can produce amorphous aggregates that 
do not resemble amyloid structure,9 or undergo a random coil to β-sheet 
transition, which leads to fibrillar aggregates and, eventually, inclusion bodies. 
With several clear pictures of the mechanism by which htt exon 1 forms fibrillar 
species beginning to emerge, a central goal of htt exon 1 research is to decrease 
toxicity, either by inhibition of the aggregation process by targeting Nt17 via a 
chaperone or proteolysis, or forcing the fibrillization pathway toward a non-toxic 
species through Nt17 modification. 
 
1.4 Targeting Nt17 for HD remediation. 
 Because Nt17 has been implicated in formation of the toxic intermediate, it 
represents a novel structural target to inhibit aggregate formation, thereby 
reducing toxicity. The most logical step in controlling Nt17 mediated amyloid 
formation is the removal of the Nt17 tract all together; a concept that has been 
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explored is targeting Nt17 via proteolysis.33, 37 A tryptic proteolytic fragment of 
Nt17Q37P10K2 (SFQ37P10K2) exhibited aggregation kinetics and morphologies 
similar to K2Q37K2, a simple polyQ peptide that lacks both flanking sequences.37 
Similarly, a MFQ37P10K2 tryptic analogue was shown to have similar kinetics to 
the true tryptic fragment.33 In vitro, these studies are simple means of studying 
Nt17-mediated aggregation, but do not represent a viable means of treatment in 
vivo, due to the difficulty of selective proteolysis. A means of inhibiting N-terminal 
aggregation is through structural complexation, either by a chaperone or an 
antibody-antigen interaction. Interestingly, Nt17 itself has been used to inhibit 
Nt17-mediated formation of Nt17Q37P10K2 multimers.26, 33 In this experiment, 
aggregation does proceed via a pathway mediated by polyQ nucleation.33 The 
mechanism by which Nt17 inhibits amyloid formation is identical to the 
mechanism by which initial association occurs, with the caveat that Nt17 alone 
does not contain an amyloidogenic tract, thereby increasing the distance 
between adjacent polyQ tracts and increasing the energy required for polyQ 
aggregation to occur.26 Other studies have focused on exogenous protein 
chaperones to inhibit aggregation.38-40  These studies show that the primary 
mode of aggregation suppression via chaperone interaction is mediation of the 
misfolded polyQ domain, not Nt17. One of the most promising treatments for 
neurological disorders stems from the use of antibodies; unlike peptide 
therapeutics and inhibitors, antibodies are specific only for the target antigen, 
which, in this case, is htt exon 1 and more specifically, Nt17. Several antibodies 
exist for htt exon 1, each recognizing a separate tract. The C-terminal polyP 
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domain is a target for antibody 3B5H10.41, 42 The antibody MW7 targets a two-
hairpin structural motif in the polyQ region.41, 43 Both antibodies have been shown 
by AFM to disaggregate polyQ amyloid fibrils.41 In the past decade, intracellular 
antibodies, or intrabodies, for Nt17 have been developed that inhibits htt exon 1 
fibrillization and cytotoxicity in vitro and cellular huntingtin models.44-46  The two 
intrabodies are C4 scFv and VL 12.3. When cotransfected with htt exon 1 (104Q) 
into COS-7, BHK-21, and HEK-293 cells, C4 scFv was shown to decrease 
aggregate formation relative to control groups that were not transfected with the 
intrabody.46 C4 scFv bound to htt exon 1 structures of non-pathogenic length 
(25Q), as well, which indicates the polyQ conformation does not play a role in 
intrabody binding, and that the most likely binding target is Nt17.46 The second 
intrabody, VL 12.3, also targets the Nt17 domain; however, unlike C4, VL 12.3 
consists of only a single chain of the typical antibody structure. The overall ability 
of this antibody to prevent aggregation is highly increased after removal of 
disulfide bonds within the antibody structure.44, 45 Interestingly, X-ray crystal 
structure of the antibody-antigen complex revealed that Nt17 was helical in the 
binding pocket of the intrabody,44 which either suggests the binding pocket 
induces helicity in the proposed random structure of Nt17, or the intrabody only 
recognizes helical Nt17. Intrabodies that were co-expressed with a pathogenic 
GFP-fused htt exon 1 (97 Q) in HEK293 mammalian cells caused a dramatic 
decrease in huntingtin inclusion bodies relative to controls. The VL 12.3 intrabody 
was at least as effective in retarding aggregate formation as the C4 intrabody,44 
as shown by fluorescence immunomicroscopy. These studies show that 
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structural inhibition of Nt17 is certainly a viable means of inhibiting aggregation 
and, potentially, htt exon 1 toxicity.  
 While many of these studies have targeted Nt17 with some success, none 
have proposed a residue-specific mechanism for Nt17-driven oligomerization. 
Aside from ssNMR, which suffers from the requirement to isotopically enrich 
residues of interest, most of the spectroscopic techniques employed only provide 
a bulk picture of peptide and protein structure, or only tangentially propose 
binding faces for Nt17 self-association and oligomer formation. A structurally 
heterogenous system like Nt17 requires techniques that can identify specific, 
coexisting structures and probe interactions in a residue-specific manner.  
 
1.5 Mass spectrometry for structural analysis.   
1.5.1. Electrospray ionization.  
 Intact protein and peptide analyses were made possible by the advent of 
electrospray ionization (ESI).47 ESI is a soft ionization technique wherein ions are 
produced by desolvation of charged droplets from a narrow emitter held at a high 
potential.47 The ionization is performed at atmospheric pressure and in typical 
cases is not energetic enough to cause fragmentation of proteins and peptides, 
though at higher ESI potentials some denaturation can occur.48 A Taylor cone is 
formed from the liquid flowing through the capillary emitter under the influence of 
the electric field. A liquid jet emerges toward the counter electrode, producing 
charged droplets. Due to solvent evaporation, droplets undergo fission as charge 
density increases. One of two primary ionization mechanisms occurs, depending 
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upon size of the analyte. Droplets containing predominantly large molecule 
analytes, such as large peptides or proteins, undergo several rounds of fission 
through Coulombic repulsion, and solvent evaporation until only the bare 
desolvated ion remains (charged residue).49 Conversely, smaller analytes, such 
as small molecule organics or single peptides, can migrate to the surface of the 
droplet and desorb from the surface, carrying with them residual charge from the 
droplet surface (ion evaporation).50 In either case, ESI produces analytes that 
may reminiscent of the native state, providing no denaturants are present in the 
solvents.48, 51, 52 Thus, ESI is most suitable for analyses of intact proteins.  
 
1.5.2 Hydrogen-deuterium exchange 
 Hydrogen-deuterium exchange mass spectrometry has been widely used 
to characterize protein structure. In solution, HDX is an acid- or base-catalyzed 
reaction (depending upon pH) that replaces amide backbone hydrogens with 
deuterons in peptide sequences. The mechanism begins with removal of the 
amide proton by OD- (at base-catalyzed physiological pH) followed by 
deuteration or rehydrogenation depending upon the relative amount of free D+ 
present in the solution 53. The rate of deuterium exchange is affected by the 
native folded state and molecular conformation. In the first equation below, kf 
represents fast HDX for exposed backbone amide linkages and ionizable side 
chains. The second equation represents slower HDX in unexposed, folded 
species.  
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Backbone hydrogen atoms that participate in hydrogen bonding, such as those 
within the confines of an α-helix, exchange much slower than hydrogen atoms 
that are not involved in a secondary structure stabilization.  
 Several studies have shown that structural interrogation is possible 
through the selective labeling of side-chain heteroatoms with deuterium atoms 
followed by gas-phase electron transfer dissociation (ETD)54 in mass 
spectrometry 55, 56. Pan et al. utilized gas-phase HDX with deuterated ammonia 
on a simple homogenous 11-residue sequence (alanine and glycine) with 
arginine and lysine at the C- and N-terminal ends, respectively. While the central 
message of the study is the use of gas-phase HDX for structural interrogation, 
they do report that under fast HDX times (approximately 6 seconds) the side-
chain and terminal amide groups are completely deuterated. Additionally, studies 
by Rand et al. confirm that side-chain deuteration may indicate elements of 
secondary structure as well as interactions associated with tertiary structure 55. 
They were able to selectively identify charge sites in native ubiquitin through the 
combination of HDX and MS/MS analysis by ETD.  
 Many analytical techniques, such as electron microscopy (EM), atomic 
force microscopy (AFM), infrared spectroscopy (IR), fluorescence imaging, and 
CD, only provide a global picture of protein aggregate morphology and 
secondary structure. Mass spectrometry (MS), however, is capable of site-
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specific analyses of intact proteins through the use of both “top-down” and 
“bottom-up” techniques coupled to isotopic labeling strategies, such as hydrogen-
deuterium exchange (HDX).57-59 “Bottom-up” HDX techniques are the most 
prevalent in the literature.60-63 For these methods, protein labeling occurs in a 
deuterium-rich solvent, such as D2O. The exchange is quenched by rapid 
addition of a highly protic solvent, such as formic or acetic acid, to pH 3 and the 
temperature is decreased to 0°C. The sample is then subjected to proteolysis, 
typically performed on-line, by an acid-active protease, such as pepsin. Following 
proteolysis, full MS and MS/MS analyses determine deuterium uptake and sites 
of deuterium exchange. This method has been used to study conformations of 
multiple proteins 57, 58, 62 and aggregate species.64 However, a hallmark of 
amyloid proteins is a resistance to proteolysis due to the rapid formation of fibrils. 
Incomplete protein digestion presents problems in the forms of decreased 
peptide signal, column fouling and line clogging. Together these problems 
present a significant challenge in bottom-up HDX studies of aggregation-prone 
proteins. 
 Recent advancements in gas-phase fragmentation in MS/MS workflows 
allow for comparable sequence coverage through top-down fragmentation of 
intact proteins using electron transfer dissociation (ETD).65, 66 Unlike collision-
induced dissociation (CID), which has been widely used in oxidative labeling 
studies,67, 68 ETD preserves post-translational modifications 69 and induces fewer 
deuterium scrambling events.58 To that end, top-down MS/MS workflows with 
ETD coupled to HDX and DHX have been routinely implemented in cases where 
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the traditional bottom-up approach is not viable, or is more error-prone. Top-
down HDX methods have been used for secondary structural characterization 
and structural transitions of intact dynamic biological systems on a millisecond 
timescale that is not possible with the more time-consuming traditional bottom-up 
technique. 70, 71 Additionally, the need for proteolytic digestion in bottom-up HDX-
MS studies can lead to loss of site-specific information due to back-exchange at 
the cleavage site. Since no proteolytic digestion is required, top-down techniques 
are also very well-suited for analysis of protein-ligand72 and soluble protein-
protein complexes.59 Early amyloid species are a specific subset of protein-
protein complex, and as such are amenable to top-down analyses. 
 Top-down studies have been performed for other amyloid proteins.59, 73 In 
this approach, the protein is allowed to aggregate in a labeling environment such 
that nearly one hundred percent deuterium incorporation is achieved. The 
resulting aggregated structure is rapidly subjected to an “exchange-out” or 
hydrogen-rich buffer to remove all solvent-exposed, labile deuterium atoms (also 
called deuterium-hydrogen exchange, back-exchange, or DHX). Next, a highly 
protic organic buffer is used to quench the DHX reaction much like in the bottom-
up technique. The high organic content causes a rapid disaggregation and 
denaturing of the protein while leaving the label intact. Examination of exchange 
sites, both from the initial deuterium uptake and DHX, yield information about the 
structure of the protein and the protein complex.  Very few studies have applied 
the top-down approach to amyloidogenic proteins and peptides; however, the 
bottom-up approach has been applied for amyloid β,74 and prion fibrils.75, 76 The 
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top-down approach has been used to characterize amyloid β 1-4059 and 1-4273 
oligomers. Pan et al. examine structural heterogeneity of amyloid β and show 
deuterium uptake is a direct result of aggregate polymorphism.73 The top-down 
approach allows for selection of specific polymorphs due to differential deuterium 
uptake. This would not be possible with a bottom-up approach, because of the 
homogenization of peptide species from pepsin proteolysis.   
 
1.5.3 Covalent labeling for residue-specific structural interrogation. 
 HDX and DHX can provide an adequate global representation of 
secondary protein structure, but it cannot completely confirm the presence of 
tertiary or quaternary interaction at a given residue. Covalent modification of a 
residue that was protected by deuterium exchange is a more direct, confirmatory 
test to determine involvement of a particular residue. Sites of covalent 
modification can be used to help determine the binding face in a given protein 
complex. Covalent modifications have been widely used to probe solvent 
accessibility of other amyloid proteins, such as β2-microglobulin.67, 68, 77 These 
studies utilized diethylpyrocarbonate (DEPC) to carbethoxylate residues that 
have heteroatom-containing side chains. DEPC targets alcohol and amino 
groups, such as those found in H, T, K, and S.  
 Residue-specific label reactions and post-translational modifications can 
sometimes compromise the structural integrity of the native protein by altering 
hydrophobicity or introducing a new intramolecular interaction not present 
previously.78 Typically, sites of covalent modification are determined through a 
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bottom-up approach; the protein is modified at increasing label concentrations, 
digested with a common enzyme, such as trypsin or chymotrypsin, and analyzed 
using reversed-phase liquid chromatography.67, 68, 78, 79 Modification can be 
reported as a normalized percent to the observed unmodified peptides. This 
percent modification can be compared in the context of complementary 
experiments, such as aggregation kinetics and/or morphology. 
 
1.6 Ion mobility-mass spectrometry 
1.6.1 Ion mobility fundamentals. 
 An ion mobility spectrometer is composed of an ionization source, a drift 
cell, and a detector.  Once volatilized, the sample is ionized traditionally by 63Ni, a 
β emitter80, 81. A packet of ions containing the analyte enters the drift region 
through a shutter grid. The grid is electronically biased to collect ions until the 
potential is dropped. A potential gradient is applied to the drift region (±1 – 500 V 
cm-1) and ions move toward the detector. When the potential on the shutter grid 
is dropped, the ion packet is allowed into the drift region where the primary mode 
of separation is related to collisions with an inert drift gas (e.g., He). Analyte ions 
within the ion packet are separated according to their mobilities through the inert 
buffer gas. Fundamentally, the mobility of an ion (K) is defined as the velocity of 
an ion through the drift tube (vd) divided by the electric field (E) as shown from 
rearrangement of Equation 1.3.  
 
𝑣! = 𝐾𝐸     (1.3) 
1. Introduction: Insights to neurodegenerative disease provided by  
deuterium exchange and ion mobility-mass spectrometry
 	   	  
17	  
 






     (1.4) 
 
Mobility is commonly reported in units of cm2V-1s-1 80, 82.  It is important to note 
that this definition of mobility refers to the average velocity for a population of the 
same ions. 81. To allow for comparisons for measurements performed on different 
instruments, and/or those employing different experimental conditions, a reduced 
mobility (K0) for the analyte ion is commonly reported. The reduced mobility is 
derived by normalizing to standard temperature and pressure as shown in 







  (1.5) 
 
Here, T is the buffer gas temperature, and P is the buffer gas pressure. 
Revercomb and Mason proposed what is now the most prevalent kinetic theory 
for ion separation in IMS 82. They assume that a) ions are approximated by hard 
spheres and b) mobility depends upon momentum transfer resulting from 
collisions with the buffer gas. They arrive at the relationship shown in Equation 
1.6, 
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where z is the charge of the ion, e is the fundamental charge, N is the number 
density of the drift gas, µ is the ion’s reduced mass, kB is Boltzmann’s constant, T 
is the gas temperature, and Ω is the collisional cross-section of the ion 82. It is 
instructive to note that mobility varies inversely with Ω; that is, the ion mobility 
decreases with increasing size due to a proportional increase in collision 
frequency.  Additionally, the mobility varies directly with charge (q) due to the 
relationship with the effective force exerted on the ion in the drift tube. 



















    (1.7) 
 
The IMS instrument used in these studies utilizes a dual-gating system. In IMS-
time of flight (ToF) MS, the ToF mass analysis is nested within the drift 
separation; ions are pushed into the ToF tube as they arrive from the mobility 
separation.83 In lieu of the ToF, the current work utilizes a linear ion trap (LIT) 
mass spectrometer. Since the LIT functions on a much slower time scale than 
the ToF, a dual-gating system is required where ions are introduced into the drift 
region by lowering the potential on a front electronic gate.84 Ions are separated in 
the drift tube until they reach a second gate. The second gate is delayed relative 
to the first, such that only ions with drift times matching the gate delay are 
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allowed into the mass spectrometer.85, 86 Collecting a mass spectrum at each 
delay time creates a two-dimensional tD (m/z) spectrum. Ions can be 
concentrated in the LIT by focusing on a single drift time and optimizing trap 
parameters. This design also allows for multiple rounds of MS/MS to be 
performed on mobility-separated analytes, which is not possible with any other 
commercially available system. This instrument lends itself well to protein and 
peptide analyses because it provides structural selection and resolution with 
multi-stage tandem mass spectrometry. 
 
1.6.2 Ion mobility-mass spectrometry in bioanalysis and amyloid study. 
 The structural heterogeneity of the htt system suggests the need for direct 
measurement of individual monomer and multimer species. High-resolution 
techniques, such as NMR, have been crucial to elucidating fibril structure;4, 11, 35, 
87 however, labeling multiple residues, as in the case for NMR, can become cost-
prohibitive. Additionally, other spectroscopic methods, such as CD, only offer a 
global view of protein structure, as it cannot differentiate the structure of 
individual, coexisting protein or peptide conformers. Systems, such as Nt17, 
where structural heterogeneity could be a critical determinant in oligomer 
formation, require structurally selective methods to fully comprehend the interplay 
of secondary structure content and multimer formation. The work described in 
this document, in particular Chapters 3 and 4, utilize IMS-MS for structural 
characterization of peptide ions in the form of collision cross section 
determinations (see Equation 7, section 1.6.1). This cross section can be related 
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to discrete secondary, tertiary, and quaternary structure through comparisons to 
in silico structures.88-95 If the protein is ionized at a low-energy, under native 
solution conditions, the gas-phase structures that are observed may be related to 
the solution structure.51, 96, 97 The observation of individual ion populations 
exhibiting different collision cross sections suggests the presence of multiple 
solution conformations.96, 98 Collision cross sections can also track 
conformational abundances as a function of solution conditions.98, 99 
 IMS-MS has seen widespread use in structural characterization of 
carbohydrates, peptides and proteins.51, 98, 100-109	  Traditional drift tube IMS 
(DTIMS), consisting of stacked ring electrodes providing a constant electric 
field83, 84, 100 is used in the current study to examine native structural 
heterogeneity of a system whose oligomerization is predicated on formation of an 
amphipathic α-helix (Nt17).12, 26 The conformational resolution afforded by IMS is 
used to determine effects of covalent modification on secondary structure 
stability and multimer formation. Here, IMS-MS is used to directly monitor various 
monomer and multimer comformers. 
 IMS-MS has been used extensively in aggregate110 and early amyloid97, 
102, 111-113 characterization, primarily for the amyloid β peptide (Aβ). Specifically, 
IMS-MS revealed an oligomerization mechanism that occurred via multimer 
association for the Aβ peptide.113 Annular hexameric structures could 
subsequently nucleate into dodecameric oligomers that are hypothesized as 
precursors for amyloid fibril formation,113 which demonstrates the ability of IMS-
MS to elucidate mechanistic details in aggregation phenomena. 
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1.6.3 Gas-phase deuterium exchange in IMS-MS. 
 Condensed-phase deuterium exchange can provide residue-specific 
information regarding solvent accessibility and secondary structure; however, the 
reliability of these methods rely on the lack of back-exchange with aqueous 
environment, as well as operation under quenched conditions, which may not be 
suitable for some protein analytes. A second option is to perform the deuterium 
exchange experiment in the gas-phase. The gas-phase exchange depends 
largely on the protein analyte conformation and accessibility of a charge site,114 
so structural information is retained.115 Much like the condensed phase 
experiments, proteins of varying conformation can still retain heterogeneous 
deuterium uptake patterns in the gas phase.86, 116, 117 One of the biggest 
advantages of gas-phase HDX is the lack of unwanted back-exchange to the 
bulk conditions, though deuterium scrambling by harsh MS environments is still a 
consideration.  
 Unlike solution phase exchange, which is catalyzed by the presence of 
OD- species and proceeds via a mechanism in which all available heteroatomic 
sites are labeled,118 gas-phase exchange proceeds by a relay mechanism in 
which the charge site and a less basic site of the peptide must be within proximity 
of one another.119 Additionally, heteroatomic sites that are buried within tertiary or 
quaternary arrangements such as salt bridges or other intermolecular interaction 
are not exchanged. The exchange begins with the establishment of a hydrogen 
bond between the charge site and an oxygen atom on D2O. A second hydrogen 
bond is established between the less basic site on the peptide and the deuterium 
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in the D2O molecule. The deuteron is transferred to the hydrophile, with 
concominant abstraction of a proton from the charge site. Subsequently, the 
deuteron may be abstracted by another basic site within the peptide. Thus, 
peptides with less accessible heteroatomic exchange sites are deuterated to a 
lesser extent than those with exposed heteroatom sites.  
 In some of the earliest work, three non-interconverting gas-phase 
cytochrome c conformers, that underwent deuterium exchange in the confines of 
a Fourier-transform ion cyclotron resonance MS (FTICR-MS), were observed, but 
not structurally resolved.117 Deuterium exchange after high-energy collisions then 
showed that at least six states are populated in the gas-phase, with deuterium 
uptake kinetics directly correlated with charge116 and, most importantly, lack of 
secondary structure. These studies showed that conformational heterogeneity is 
not only sampled in the gas-phase, but that by measuring the incorporation of 
deuterium atoms one could surmise the number of non-covalent interactions 
present in a given conformer. Since gas-phase deuterium exchange occurs on 
the order of µs,114-117, 119 it can be performed simultaneously with IMS, in which 
residence time in the drift tube occurs on a ms time scale. Conformations of 
cytochrome c were simultaneously dispersed and deuterium-labeled in IMS,115 
which demonstrated that compact conformations experienced fewer deuterium 
exchange events due to hydrogen protection. Deuteration levels observed in the 
FTICR experiment were much higher than those performed in the IMS 
separation, possibly because the FTICR was sensitive to longer time scale 
structural fluctuations. The benefit of gas-phase exchange in the IMS is the ability 
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to structurally resolve each conformation, thus providing an extra layer of 
specificity.  
 The full utility of gas-phase deuterium exchange was not realized until 
recently;55, 85, 86 the advent of tandem mass spectrometry for mobility-resolved 
conformations via ETD allows for determination of deuterium incorporation sites 
without little consideration for deuterium scrambling.120 This technique can then 
be used to determine exact sites of hydrogen accessibility and uptake in gas-
phase structures and validate candidate structures generated by MDS.86 A 
kinetic model was developed to relate deuterium uptake to charge site and 
carbonyl accessibility on model structures.121 Additionally, more recent 
experiments further detailed that charge site accessibility is required for 
increased deuterium exchange. Thus, in some cases, compact, lower charge 
conformers of a given peptide ion can have more deuterium exchange events 
than a higher-charge, more elongated conformation.86 Other studies have 
examined conformational rigidity with respect to disulfide bonds and Coulomb 
repulsion in deuterium exchange studies.122 In the current work, gas-phase 
deuterium exchange is used to probe accessibility of a heterodimeric complex 
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1Reproduced with permission from the Journal of Mass Spectrometry: Lysine residues in the N-
terminal huntingtin amphipathic α-helix play a key role in peptide aggregation. Arndt, J. R., 
Brown, R. J., Burke, K. A., Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 50, 
117-126. Copyright © 2015 John Wiley & Sons, Ltd. 
 
Huntington’s Disease (HD) is a genetic neurodegenerative disorder caused by an 
expansion in a polyglutamine domain near the N-terminus of the huntingtin (htt) protein 
that results in the formation of protein aggregates. The focus of the study is on the 17 
residue N-terminal flanking region of the peptide (Nt17) that has been shown to alter htt 
aggregation kinetics and morphology. A top-down sequencing strategy employing 
electron transfer dissociation (ETD) is utilized to determine the location of accessible 
and protected hydrogens in the aggregate. Evidence for protected residues is observed 
in the Nt17 tract and specifically point to lysine residues as potentially playing a 
significant role in htt aggregation.  
 
2.1 Introduction: The case for deuterium exchange MS in HD characterization 
 Huntington’s disease (HD) is a fatal neurodegenerative disease caused by an 
expanded CAG repeat in the huntingtin gene that codes for a polyglutamine (polyQ) 
region in exon 1 of the huntingtin (htt) protein.1 Neurotoxicity is thought to derive from 
the aggregation of the polyQ tract and has been shown to be repeat-length dependent 
with an expansion beyond ~35Q representing the threshold for initiating HD.1-3 Although 
expansion of the polyQ region drives aggregation, the seventeen-residue N-terminal 
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flanking sequence (Nt17) enhances aggregation rates by promoting the formation of an 
oligomeric intermediate to fibril formation in vitro, 4, 5 and altering Nt17 is an effective 
strategy to modify the aggregation process.6 Nt17 has been shown to contain α-helical 
content by a variety of techniques, including circular dichroism (CD), 4, 7 nuclear 
magnetic resonance (NMR),8 molecular dynamic simulations,9 and x-ray 
crystallography.10 This a-helix is amphipathic in nature, driving htt's interaction with lipid 
membranes.5, 11-15 This amphiphilic, helical nature of Nt17 appears to underlie its ability 
to enhance fibril formation, nuclear accumulation, and toxicity.7, 16 As a result, 
considerable effort has been aimed at elucidating the fate of the Nt17 domain in the 
various aggregate forms of htt.8, 17, 18  
 Huntingtin aggregation is thought to occur through a complex mechanism with 
several possible structural intermediates.4, 19 A tetrameric species, whose formation is 
driven by Nt17, may represent the critical nucleus for aggregation.4 Inter-helical 
interaction associated with Nt17 is believed to be primarily hydrophobic in nature.16, 20 
Furthermore, mutations or modifications in the Nt17 domain slow aggregation, 
specifically serine phosphorylation or serine mutation to arginine.21-23 Curiously, these 
modifications fall in the hydrophilic region of the helix, suggesting that more than the 
hydrophobic interaction drives inter-helical association. Elucidating specific interactions 
in the formation of htt aggregates is a primary focus within the field 8, 11, 16, 24 with far 
reaching implications in devising therapeutic strategies.6, 23 The arguments presented 
above demonstrate that adequate structural characterization of htt aggregate species 
requires a residue-specific analysis. HD-related peptides have traditionally been studied 
by spectroscopic and microscopic techniques.8, 13, 17, 19, 25-28  
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 The purpose of this study is to extend these top-down proteomics techniques for 
the elucidation of the three-dimensional arrangement of an aggregation-enhancing tract 
in a truncated htt peptide.8 This truncated peptide contains the Nt17 domain, a 
polyglutamine domain 35 residues in length (representative of disease threshold), a 10 
residue polyproline domain, and two lysine residues on the C-terminus side of the polyQ 
domain to aid in solubility. Here, this peptide will be referred to as Nt17Q35P10K2. The 
aggregates formed from this synthetic model do not significantly differ from those 
formed from htt exon 1 cellular constructs. The C-terminal lysine residues do slightly 
increase aggregation kinetics relative to a full htt exon 1 construct; however, 
morphologically, aggregates are morphologically indistinguishable at identical time 
points.29 Thus, the C-terminal lysine residues have little bearing on aggregate kinetics or 
morphology.29 This represents the first time top-down mass spectrometry techniques 
have been applied for structural characterization of htt aggregates.  
 
2.2. Materials and Methods  
2.2.1. Sample Preparation.  
 Synthetic Nt17Q35P10K2 was purchased from the Keck institute (Yale University) 
and stored at -20° C until later use. Disaggregation and solubilization of peptides was 
achieved by a variation on published protocols.30 In short, 4.0 mg portions were 
dissolved in 1.00 mL of 50/50 trifluoroacetic acid/hexafluoroisopropanol (TFA/HFIP) to 
ensure disaggregation. The samples were aliquoted into 250 µL portions and dried 
under a steady stream of nitrogen until most of the TFA/HFIP was removed. The 
aliquots were then placed in a centrifugal evaporator for two hours to ensure removal of 
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all TFA/HFIP. The resulting 1.0 mg peptide films were stored at -20° C until further use. 
The peptide films were reconstituted in 20 µL of pH 3 TFA and diluted ten-fold into D2O 
with 100mM ammonium acetate (labeling buffer, pH 7.0) to obtain a final concentration 
of ~5.0 mg·mL-1. This peptide concentration, although above the normal physiological 
level, compensates for the loss in signal due to dilution into the DHX buffer. Typical 
protocols call for the use of phosphate or tris buffers for incubation; however, those are 
not suitable for mass spectrometry. For this reason, ammonium acetate was chosen, as 
it is a much more amenable salt for mass spectrometry, as a pH stabilizer. Samples 
were allowed to rest in the labeling buffer on the bench top for thirty minutes. This 
labeling time was chosen for two reasons: the time scale is kinetically favorable for 
complete labeling of the peptide (both side chains and backbone); and, fibrils formed at 
this timescale. 
 
2.2.2. Thioflavin T Assay.  
 The assay was performed using a Molecular Devices M5 spectrophotometer 
(Molecular Devices, LLC, Sunnyvale, CA). Stock thioflavin T (Sigma Aldrich, St. Louis, 
MO) was prepared in nanopure water at a concentration of 1.0 mg·mL-1. Peptide 
samples were prepared as described above. 2.0 µL of the stock thioflavin T was spiked 
into the sample (100 µL total sample volume/well). Sample fluorescence was monitored 
using 440nm excitation and 480nm emission wavelengths. Samples were kept at 25° C 
for the duration of the assay. Emission data points were acquired every minute for three 
hours in each sample buffer (labeling, DHX, and disaggregation). Background 
fluorescence was obtained from a blank sample that contained no peptide, collected 
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simultaneously with the analyte. The background signal did not deviate more than ±0.44 
in intensity. Each peptide sample was run in triplicate and averaged. The average 
background signal was subtracted from each data point in the spectrum to obtain the 
actual fluorescence associated with β-sheet formation. Signal was normalized to the 
highest intensity value for each trial. 
 
2.2.3. Atomic Force Microcopy.  
 Peptide solutions were sampled after 0, 30, and 180 minutes of incubation. At 
each time-point, 5 mL aliquots of solution were deposited on freshly cleaved mica for 1 
minute, washed with 200 mL of ultrapure water, and dried with a gentle stream of 
purified air. Each substrate was imaged in air with a Nanoscope V MultiMode scanning 
probe microscope (Veeco, Santa Barbara, CA) equipped with a closed-loop vertical 
engage J-scanner and operated in tapping mode. Images were acquired with diving 
board shaped silicon cantilevers with a nominal spring constant of 40 N/m and a 
resonance frequency of ~300 kHz. AFM image analysis was performed using Matlab 
outfitted with the image processing toolbox. (MathWorks, Natick, MA). To distinguish 
between oligomeric and fibrillar aggregates in AFM images, an aspect ratio (defined 
as Ra = r1/r2, with r1 being the largest and r2 being the shortest distances across an 
aggregate) filter was used.31 Oligomers were defined as any aggregate at least 1 nm in 
height with an aspect ratio less than 2.5, indicating a globular structure. Fibrils were 
defined as aggregates greater than 1 nm in height with an aspect ratio greater than 2.5, 
which corresponds to an elongated fibrillar structure.  
  
2. Lysine Residues in the N-Terminal Huntingtin Amphipathic α-Helix  
Play a Key Role in Peptide Aggregation   	   40 
2.2.4 DHX Tandem Mass Spectrometry.  
 Samples were prepared as described above, with the addition of a 0.1 mg/mL 
bradykinin internal standard (0.01 mg/mL final concentration). After labeling, the sample 
was injected onto an LTQ Velos Pro linear ion trap mass spectrometer (Thermo 
Scientific, San Jose, CA) using a 0.100 mm I.D. fused silica capillary at a flow rate of 
0.5 µL·min-1. Electrospray ionization ESI emitter tips were pulled from untreated fused 
silica capillary and the ESI potential was maintained at 1.80 kV above the MS entrance 
orifice (180°C). Water with 0.100M ammonium acetate was used as the DHX buffer. 
On-line quench and disaggregation after DHX was achieved by acetonitrile with 10% 
acetic acid. The DHX and disaggregation buffers were introduced sequentially using 
low-volume microcross assemblies (Upchurch Scientific) at flow rates of 1.0 and 0.5 
µL·min-1, respectively. The sample was exposed to the DHX buffer at room temperature 
(25°C) over a 2.2 in. mixing region, corresponding to 17.6 seconds of exposure time. 
Quench and disaggregation was performed over a 3.5 in. length of capillary, which 
corresponds to 21.2 seconds of quench and disaggregation. Jorgensen et al. report that 
back exchange is negligible for a lysine-containing peptide fragment exposed to an 
acidic quench buffer for under thirty seconds.32 Full MS scans as well as ETD MS scans 
for the most abundant charge state peaks were acquired for the unlabeled sample, the 
labeled sample, and the DHX sample. Unlabeled samples were prepared in the same 
manner as the labeled samples, except the solvent was switched to H2O. In both cases, 
the disaggregation buffer was used. This provided a direct comparison of ETD mass 
spectra without the reliance on in silico fragmentation, though this method was used 
initially to determine peaks of interest. Fully labeled ETD spectra were acquired for each 
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charge state without the use of the DHX buffer. Ions were accumulated in the trap for 75 
ms with a 4.0 m/z window to ensure adequate ion coverage. Each spectrum was 
averaged for five minutes. Before DHX experiments were performed with the htt 
peptide, a bradykinin DHX experiment was performed to determine the point at which to 
collect the spectra. Bradykinin was allowed to incubate in the labeling buffer for thirty 
minutes. A full MS scan was observed for the fully labeled peptide. The sample was 
then exposed to the DHX buffer until the [M+H]+ bradykinin signal did not change 
significantly (approximately five minutes, data not shown). This value was used to 
determine the time at which to start acquisition of the htt DHX spectra. 
 
2.2.5. DHX Data Analysis.  
 The centroid m/z from each isotopic envelope was selected manually and used 
as the peak for determining exchange levels. The list generated from ETD-MS of each 
charge state for the unlabeled samples was cross-referenced with an in silico 
fragmentation pattern list (c- and z- type ions) generated from Protein Prospector’s MS 
Product tool (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct). Peaks were assigned to the respective c- or z- ion 
label if the actual value did not vary from the theoretical by more than ±0.5 m/z. The 
peak list generated from the labeled charge states was compared to a theoretical list 
generated by adding a theoretical total deuterium uptake (sidechain + backbone) to the 
obtained ETD-MS values. Here, uptake for ion ci+1 must not be significantly less (-1 
deuterium) than ci. The DHX peaks were also found manually; however, labels were 
assigned to each ion if their m/z value fell between the unlabeled and labeled value for 
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the same ion. As with the labeled sample, m/z values for ci+1 could not be less than ci. 
Each figure represents an average of three individual experiments run under identical 
conditions on separate days. Intrinsic D-to-H exchange rates were calculated for 
comparison purposes using Sphere 
(https://www.fccc.edu/research/labs/roder/sphere/sphere.html). Exchange conditions 
were set to pH 7.0 with default pKa values used for glutamic acid residues and the C-
terminus (4.5 and 3.72, respectively).   
 
2.3 Results and Discussion 
2.3.1. Htt peptide predominantly forms fibrillar aggregates under experimental 
conditions.  
 The aggregation of amyloid-forming proteins is governed by a number of factors 
including solution pH and ionic strength as well as protein concentration. Because the 
goal of the this study was to characterize the structures of aggregates formed by a 
truncated htt peptide, it was necessary to survey the aggregation process under 
conditions that would be employed for the HDX-MS analyses, which deviated from 
established polyQ peptide preparation protocols30 and to determine the morphology of 
the aggregates obtained. Using a thioflavin T (ThT) assay, the aggregation profile was 
determined for Nt17Q35P10K2 in the labeling (100mM NH4OAc) or disaggregation buffer 
(acetonitrile with 10% acetic acid, Figure 2.1A). Incubation of Nt17Q35P10K2 in the 
disaggregation buffer yielded no enhancement of ThT fluorescence, confirming that the 
protein did not aggregate under these conditions. However, initiation of β-sheet 
formation occurred within minutes of incubation in the labeling buffer. The aggregation 
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rate rapidly increased for approximately the next 25 minutes and decreased thereafter, 
beginning to plateau at ~80 minutes. At longer time points (>80 minutes), the ThT 
fluorescence response associated with incubation of Nt17Q35P10K2 was indicative of a 
large degree of β-sheet content, consistent with fibril formation (Figure 2.1A).  
 
Figure 2.1 The htt peptide, Nt17Q35P10K2, readily forms fibrils. (A) Thioflavin T fluorescence 
tracked β-sheet formation of Nt17Q35P10K2, which is indicative of fibril formation. The blue 
dashed line represents the Nt17Q35P10K2 peptide in the labeling buffer; the solid green line 
represents the same sample with the addition of the disaggregation buffer. DHX-MS samples 
were taken at t = 30min (gray vertical line). All fluorescence intensities were normalized to the 
most intense overall value. (B–E): AFM analyses of Nt17Q35P10K2 peptide aggregates. (B) At t = 
0, no fibrils were present; although, a peptide film formed on the substrate. (C) After 30 min, a 
mix of oligomeric and fibrillar aggregates had formed. (D) At t = 180 min, fibrils completely 
covered the surface. (E) The average height along the contour of the Nt17Q35P10K2 fibrils was 
roughly 3.5nm. 
 
Similar to that performed previously,33 a separate experiment was conducted in 
which a 50µL aliquot of the disaggregation buffer was added to the htt-ThT assay at 
t=25 minutes (Figure 2.2). A dramatic decrease in fluorescence intensity was observed. 
The final pH of the sample after addition of the disaggregation solution was 4.2. Studies 
on insulin amyloid fibrils show that at pH 1.6, ThT loses affinity for the fibril due to 
charge repulsion between the amyloid protein and ThT.34 Since glutamine residues are 
uncharged at pH 4.2, no such charge repulsion occurs; therefore, the observed 
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decrease in fluorescence intensity is most likely due to a decrease in β-sheet content 
and not due to a decrease in ThT affinity for fibrillar polyQ. Similar studies show that 
ThT assays are effective for uncharged proteins down to pH 3.9.33  
A separate mass spectrometry experiment was performed on incubated peptide. 
Samples were prepared in the same manner outlined in the Methods section. After 30 
minutes, the sample was split into two equal aliquots. A 100µL aliquot of the 
disaggregation buffer was added to one sample, while 100µL of ammonium acetate was 
added to another. A 1.0 mg/mL bradykinin standard was added to both samples (final 
concentration: 0.01mg/mL). The samples were centrifuged at 20,800xg for five minutes 
to pellet the aggregated peptide. The supernatant was removed and dried down in a 
centrifugal vacuum concentrator until all solvent was evaporated. Both of the resulting 
films were reconstituted in 50/50 water/acetonitrile with 0.1% acetic acid and 
electrosprayed immediately. The ion intensities of all Nt17-Q35-P10-K2 charge states 
were summed and normalized to the total ion intensity of bradykinin. The Nt17-Q35-P10-
K2:Bradykinin ratio for the NH4OAc sample was 0.11, while for the ACN/HOAc sample, 
the ratio was 0.41; four-fold more peptide was found in the supernatant of the 
disaggregated sample versus the control. This suggests that the high-organic, low pH 
disaggregation buffer dissolves at least part of the aggregated sample, perhaps those 
that are in an early transient complex. The decrease in β-sheet content can be 
associated with partial disaggregation, suggesting a portion of species that are 
observed in later mass spectrometry experiments originated from an aggregated state. 
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 To characterize aggregate 
morphology, the Nt17Q35P10K2 
incubations were sampled at several 
time-points for AFM analysis. Despite 
the short lag phase for the initiation of 
aggregation in the labeling buffer, the 
initial prep was predominately un-
aggregated as determined by AFM 
analysis of freshly prepared peptide, 
i.e., at time-point 0 minutes (Figure 
2.1B). Freshly prepared peptide 
formed a perforated film on mica, 
indicative of soluble protein depositing onto the surface. Consistent with the ThT assay, 
Nt17Q35P10K2 formed a significant number of fibrils after 30 minutes of incubation in the 
labeling buffer (Figure 2.1C), and the number of fibrils increased at 180 minutes, 
covering the entire surface in a dense mesh (Figure 2.1D). While there were a few 
globular aggregates observed at 30 minutes that represent oligomers, fibrils were the 
dominant species (> 98% by total volume of deposited peptide in aggregates as 
determined by AFM image analysis, Figure 2.3). After 30 minutes of incubation in the 
labeling buffer, the average height along the contour of a fibril was predominately 3-4 
nm; however, this height increased to 5-8 nm as fibrils bundled together (Figure 2.1E).  
 
Figure 2.2. Disaggregation of Nt17Q35P10K2 by 
addition of ACN/HOAc (90/10). Blue line: 
thioflavin T fluorescence of Nt17Q35P10K2 in 
NH4OAc buffer. Green line: disaggregated 
Nt17Q35P10K2. All experiments were performed in 
triplicate and averaged.  
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Figure 2.3. AFM image of Nt17Q35P10K2 on mica at t = 30. Yellow triangles indicate fibril 
structures; blue triangles indicate oligomeric structures. Each panel represents a different part of 
the sample. Percent oligomer content was calculated to be less than 2%. 
  
 It is important to note that the kinetics of peptide aggregation in this study was 
accelerated relative to previous studies with similar peptides4 due, in part, to an 
increased peptide concentration and potentially differences in the aggregation buffer. It 
is known that aggregation kinetics of polyQ and htt exon1 increases with 
concentration.35 It is also well-known that sample preparation and buffer conditions can 
greatly influence the formation of amyloid structures, both kinetically and 
morphologically.30 The aggregation profile associated with incubation in both buffers 
results in important implications for the following structural analysis using DHX-MS-MS. 
The high organic, low pH disaggregation buffer, the same used in the initial ThT 
experiments, prevented aggregation over the experimental time period (Figure 2.1A), 
which is consistent with high organic solvents traditionally being used as protein 
denaturants in bottom-up proteomic experiments. β-sheet character is non-existent with 
the addition of the disaggregation buffer. This buffer also served to quench the 
exchange reaction. The electrospray ionization process occurred approximately twenty 
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seconds after disaggregation. This prevented undesired back-exchange of newly 
exposed exchange sites similar to that shown in other studies using standard 
peptides.36  
 Control experiments were 
conducted to insure no deuterium 
scrambling occurred in the mass 
spectrometer (Figure 2.4). The peptide 
KKDDDDDIIKIIK was purchased from 
Genscript, Inc. (Piscataway, NJ) and 
treated according to protocols outlined 
by Zehl et al. It should be noted that 
Zehl et al. used a hexa-aspartate tract, 
while this control utilizes a penta-
aspartate tract. Briefly, peptide was 
incubated in 99% D2O for 18 hours at 
25°C to ensure full deuteration. This peptide contains a fast-exchanging dilysine penta-
aspartate tract at the N-terminal region and a slow-exchanging IIKIIK tract at the C-
terminal end. It is assumed that upon introduction to a DHX solution in the absence of 
deuterium scrambling, that the N-terminal region will back-exchange quickly, while the 
C-terminal portion will retain its deuterium. In the case of scrambling, one would 
observe even distribution of deuterium to all available sites. The peptide was subjected 
to the same on-line DHX procedure as the Nt17Q35P10K2 peptide, at the same flow 
rates. Our experimental data matches closely with that of a 0% scrambling model. 
 
Figure 2.4. Scrambling controls. Red line: 
100% scrambling, Blue line: 0% scrambling, 
Green line: experimental data. Nearly full back-
exchange in the N-terminal half of the peptide 
and retention in the C-terminal half is observed.  
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Additionally, we do not observe deuterium retention on the N-terminus, which is also 
indicative of deuterium scrambling. Therefore, we can conclude, that under our 
experimental conditions, no deuterium scrambling is occurring. 
 
2.3.2. Full MS of Labeled Nt17Q35P10K2 Demonstrates Six Distinct Charge States.  
 The ESI mass spectrum of native, aggregated (t = 30 minutes, Figure 2.6A and 
B) Nt17Q35P10K2 peptide after introduction of the disaggregation buffer shows the 
generation of six charge states ([M+5H]5+ to [M+10H]10+ (see Figure 2.5 for on-line DHX 
schematic).  
 
Figure 2.5. On-line DHX schematic. Untreated fused silica capillary was used for all mass 
spectrometry experiments. Sample is pumped into the first microcross assembly at a rate of 
0.5µL/min. DHX solution was introduced at a flow rate of 1.0µL/min, resulting in a total DHX time 
of 17.7 seconds along the 2.2in. capillary. The inlet for this solution was capped for experiments 
in which no wash was used. The disaggregation/quench solution was introduced at the second 
microcross at a flow rate of 0.5µL/min, resulting in 21.2 seconds of disaggregation. The end of 
the region was pulled into an ESI emitter and used for nanospray ESI-MS. 
 
The maximum charge state observed in the ESI distribution was the [M+10H]10+ 
species. The [M+8H]8+ was the most intense feature in the ESI charge state distribution, 
and a significant decrease in intensity was observed for the [M+5H]5+ charge state. Of  
	   	  
Sample In 
DHX Solution: H2O, 
0.100M NH4OAc 
Disaggregation/Quench Solution: 
Acetonitrile/Acetic Acid 90/10 
DHX Region: 2.2in. Disaggregation/Quench 
Region (to ESI): 3.5in. 
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these, only three were used for by residue 
fragmentation analysis ([M+7H]7+ to 
[M+9H]9+) because the higher charge 
states are more amenable to the 
production of informative ETD 
fragmentation spectra.37, 38 The 
[M+10H]10+ was omitted from ETD studies 
due to poor ion statistics and low signal.  
Each charge state was observed 
as a multiplet peak in the ESI mass 
spectrum (Figure 2.6B). Comprising 
peaks differed by ~128 Da, indicating that 
these species correspond to peptides with 
truncated polyQ domains (i.e., < 35Q) and 
were presumably remnants of peptide 
synthesis. For each charge state, only the peak corresponding to peptides containing 
exactly 35Q repeats was analyzed; however, heterogeneous aggregation (e.g., 35Q 
interaction with 34Q or 33Q) cannot be ruled out. Such a scenario is possible, as EPR 
analysis of fibril structure of similar htt peptides demonstrated that the polyQ domain 
does not need to be in register within the fibril structure.17 Ions associated with single 
peptide sequences are observed to contain varying numbers of solvent adduct 
molecules, +17 Da, most likely NH3, as well as some oxidation on M1 as shown in 
 
Figure 2.6. Full mass spectrum of the 
unlabeled Nt17Q35P10K2 shows six 
accessible charge states. (A) Six charge 
states are observed for the sample 
ranging from [M+ 5H]5+ to [M+ 10H]10+. (B) 
Each charge state manifests as a multiplet 
with the most intense peak representing a 
Q35 chain.  
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Figure 2.6B. In each case, the non-adducted, non-oxidized ion was selected for ETD 
analysis after HDX and DHX.  
  
2.3.3 Protein HDX and DHX exchange levels.  
 For the experiments described below, the Nt17Q35P10K2 peptide was incubated in 
the labeling buffer for ~30 minutes prior to initiation of MS measurements. To determine 
the maximum level of deuterium incorporation, the incubation solution was 
electrosprayed directly into the mass spectrometer. Table 2.1 lists the numbers of 
deuterium atoms that were incorporated into the protein ions for each of the observed 













9 119.97 39.69 80.28 9.58 30.11 
8 116.64 44.00 72.64 9.97 34.03 
7 118.72 42.84 75.88 9.83 33.01 
6 120.06 48.00 72.06 - - 
5 118.75 42.10 76.65 - - 
Average 118 ± 1 43 ± 3 75±3 9.8±0.3 32±2 
Table 2.1. Total Deuterium Uptake and Retention by Charge State  a Charge states of each 
peak were obtained using a Thermo Q Exactive FTMS under the same source conditions as the 
LTQ Velos. b Deuterium uptake calculated by subtraction of the unlabeled mass from the 
labeled mass for each charge state. c Deuterium retention after DHX and quench step 
calculated from subtraction of the native peptide mass from the mass after DHX. d Deuterium 
removed by DHX calculated by subtraction of the mass after DHX from the fully labeled mass. e 
Deuterium retained in the Nt17 region calculated from the c15 ion. f Deuterium retained in the 
polyQ region calculated by subtraction of D Retained, Nt17 from total D Retained. 
	  
	  
On average, the maximum number of deuterium atoms incorporated into the 
molecule was 118±1, corresponding to ~85% of potential exchange sites. There are 
several possible explanations that would explain the lack of complete deuteration. One 
is that upon exposure to the quench/disaggregation buffer, rapidly exchanging side 
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chain hydrogens undergo back exchange. It is noted that previous HDX exchange 
studies of amyloid-β, a combined wash/disaggregation buffer was used that consisted of 
water/acetonitrile/formic acid (50:50:0.1).36 In these experiments, the solution served to 
quench the HDX reaction as well as disaggregate the sample. However, the latter buffer 
contains a significant source of protons that could potentially contribute to back 
exchange. To decrease artifactual back exchange in the present study, a 
quench/disaggregation buffer resulting in an ESI tip proton:deuteron ratio of ~1:40 was 
employed after DHX. That said, back exchange cannot be completely ruled out in 
explaining the deuterium uptake deviations. A second explanation is that solvent 
exposure decreases due to inter- or intra-molecular interaction for some residues which 
would cause protection of some side-chain and backbone hydrogens. 
Exposure of the htt peptide, via an online wash, to an aqueous back-exchange 
buffer (100mM NH4OAc) followed by the quench/disaggregation buffer resulted in 
removal of ~64% of the deuterium atoms (Table 2.1).  The deuterium retention suggests 
a high degree of interaction at t=30 minutes, some of which could be due to 
aggregation. The observed peptide cannot unambiguously be differentiated from 
originating from an aggregated or monomeric state; however, a four-fold increase in 
monomeric peptide is observed in a filtered sample containing the disaggregation buffer 
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2.3.4 Deuterium Uptake by Residue – H-to-D-exchange (HDX) demonstrates deviation 
from maximum uptake.  
 Subjecting select protein charge states 
(+7 to +9) to ETD yields primarily c-type ions. 
These ions comprise a nearly complete 
series from the N-terminus containing each 
residue in the N-terminal sequence at the 
cleavage site. Site characterization is  
focused on the c-ion series for two reasons: 
the N-terminal region is implicated in 
modulating aggregation kinetics and 
promoting specific aggregate forms27 and the 
large polyP tract at the C-terminal region 
affords no information because it does not 
readily fragment via ETD. Each c-ion that is 
created contains a reduced carbonyl group 
that originates from a charge (basic) site.39 It 
is noted that in HDX experiments, this means 
donation of a proton or, more likely, a 
deuteron. That said, in comparisons to the 
theoretical maximum uptake (Figure 2.7), this 
site is added to the sum of exchange sites for 
each ion. 
 
Figure 2.7. N-terminal region of the 
Nt17Q35P10K2 peptide is solvent 
exposed and contains secondary 
structure in the aggregated form. (A) 
Fragmentation pattern for the Nt17 region. 
(B) Total deuterium uptake by ion before 
(red circles) and after (green squares) 
DHX. Blue markers represent full 
theoretical deuterium incorporation for 
each ion. (C) Deuterium uptake and 
retention by residue. Red circles are 
calculated uptake by residue. Green 
squares are calculated retained deuterium 
by residue. Error bars represent a 
propagation of error originating from the 
average of three MS measurements per 
charge state. The error was carried 
through all arithmetic . 
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The average deuterium uptake (HDX experiments) of each ion in the c-ion series 
increases linearly, with some deviation from theoretical (Figure 2.7B). The c1 ion has a 
theoretical uptake that is one higher than that expected for the acetylated amino acid 
residue due to the charge site. Thereafter, the charging deuteron is not counted. That is, 
each subsequent theoretical uptake value is calculated by adding the number of 
exchangeable side chain and backbone hydrogen atoms to the preceding ion. For 
example, c1 (M) has a theoretical uptake of three deuterium atoms (a backbone, a 
reduced carbonyl from the ETD mechanism40, and a charge). c2 (MA) has a theoretical 
uptake equal to c1 plus an additional backbone site.  
For the first 5 residues, the deuterium uptake levels and deuterium increase per 
ion are very near that expected for complete uptake (Figure 2.7B). At the c6 ion a 
greater deviation from the maximum theoretical values is observed. From c6 to c11 
deuterium increase per residue is very similar to the theoretical values for complete 
uptake. The c12 ion, like the c6 ion, exhibits an increase in deviation from the 
experimental that is preserved to the c15 ion. Overall, it appears that, with the exception 
of a few residues, complete deuterium uptake is observed across the first 15 amino acid 
residues. The deviations from the maximum uptake values at residues K6 and E12 
could result from one of two different phenomena. The first is that during the 
aggregation process, these residues become involved in important interactions resulting 
in protection of hydrogens and no deuterium uptake is observed. The second 
explanation is that upon addition of quench/disaggregation buffer, DHX occurs resulting 
in the incorporation of hydrogens. Even though the proton:deuteron ratio is low (~1:40) 
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at the ESI tip for these HDX experiments (see above), the latter explanation could 
explain the observed results.  
The deuterium uptake data can also be described in terms of the amount of 
deuterium incorporation per amino acid residue (Figure 2.7C). The uptake by residue is 
determined by subtracting the uptake value (Figure 2.7B) of the immediately preceding 
c ion from that of the ion of interest. In general polar residues (with heteroatom 
exchange sites) exhibit significantly more than one deuterium uptake per residue. 
Residues exhibiting the greatest uptake include M1, T3, K9, and K15. It is noted that we 
do not consider S13 because the c13 ion is not observed and exchange values for S13 
(and L14) are computed as averages between adjacent residues as performed 
previously41. Interestingly, the polar E12 residue exhibits a relatively low uptake value. 
As mentioned above, this deviation could result from back exchange or from an 
important interaction associated with aggregates. The remaining non-polar residues in 
this region of the protein all show complete uptake of 1 deuterium with the exception of 
L4 (Figure 2.7C). The reason for incomplete uptake is not known; however, the larger 
error associated with this measurement is noted, indicating that ion statistics could 
contribute to the skewed result. 
 
2.3.5 Deuterium protection by residue - D-to-H-exchange (DHX) demonstrates 
protection in Nt17.  
Increased understanding of the structure of the N-terminal region of the htt 
protein as well as the role of certain residues within aggregate structure is obtained from 
ETD of the DHX protein ions. The c1 ion shows that essentially all of the deuteriums 
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have been removed by DHX (Figure 2.7B, green squares). The c2 ion shows protection 
of ~1 deuterium. From the c2 ion to the c15 ion some protection of deuteriums is 
observed increasing from ~1 deuterium to ~9 deuteriums by c15. The increase in 
retained deuteriums (Figure 2.7B) is relatively constant (~0.5 deuteriums per residue) 
with the exception of the transition from the c5 ion to the c6 ion (~1.5 deuteriums). After 
c6 there is a gradual increase until c12 with a slight increase from c12 to c15. It is noted 
that the c13 and c14 ions are computed as averages and so it may be possible that the 
slight uptake in deuterium protection is evenly distributed across the c13 to c15 residues; 
however, it is also possible that there is a significant increase in protection at the c15 
residue. 
The DHX provides confirmatory and additional information regarding protein 
structure. DHX-ETD-MS experiments suggests that the N-terminal region is solvent-
exposed in the aggregated form as the N-terminal residue (M) and unprotected side-
chain deuterium atoms from other residues are removed by solvent dilution into H2O. If 
the N-terminal region were concealed in the center of the aggregate, a higher degree of 
deuterium retention may be expected; that is, retention would be closer to theoretical 
backbone values due to decreased solvent accessibility and intermolecular and 
intramolecular H-bonding. However, the observed deuterium retention indicates that 
Nt17 is located, at least partially, on the periphery of the aggregate structure.  
 The decreased protection of backbone amide hydrogens in the N-terminal region 
stands in contrast to the protection observed in the remaining portion of the protein. 
Approximately ten deuterium atoms are retained in the Nt17 region of the peptide, while 
an average of 43 are retained over the entire peptide. Because proline does not contain 
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exchangeable hydrogens, the remaining deuterium must reside in the polyQ region 
(Table 1). Assuming that upon disaggregation, the polyQ sidechains rapidly back 
exchange, the protection of amides must be near that of unity, higher than that 
observed for the N-terminal region. In summary, although our ability to probe the polyQ 
region was limited as many of the associated fragments were outside the range of the 
ion trap, the available data conforms to the notion that the polyQ domain forms a rigid 
core in the fibril, which is further supported by both the ThT and AFM data. Such a 
scenario is consistent with multiple proposed structures for polyQ packing in fibrils.8, 26, 
42, 43 
 
2.3.6 HDX and DHX by residue show increased protection on lysine residues.  
 A number of polar residues exhibit increased deuterium protection relative to the 
0.6 average deuterium retention value (Figure 2.7C). It is instructive to consider whether 
or not this may result from stabilizing interactions for the aggregate structure. The 
residue that exhibits the most protection is K6 (Figure 2.7C). As noted above, uptake at 
this residue is approximately two deuterium less than theoretical (Figure 2.7B). The 
deuterium that is incorporated is nearly all retained in the DHX experiment, as only ~0.6 
deuteriums back exchange for hydrogens (Figure 2.7C). This is an important 
observation because deuterated lysine side chains in Nt17 have been shown to quickly 
back-exchange in solution.8, 44 Therefore, this observation may indicate a critical role for 
K6 in stabilizing aggregate structure. In contrast, nearly full uptake for the K9 residue is 
observed with subsequent back-exchange to an ~0.6 deuterium average suggesting 
that this side chain is rapidly back-exchanged and not involved in any interaction. Other 
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residues that exhibit deuterium protection levels that are greater than the 0.6 average 
include T3 and K15. Although, the protection levels for these two residues are less 
pronounced than that of K6, the potential roles of these residues warrant further 
investigation. It is important to note that the S13 residue protection is obtained from the 
average value assigned to the c13 ion and should be treated with caution.  Intrinsic 
exchange rates of the selected residues were calculated. Rapid back-exchange of K9 is 
not surprising, since its intrinsic D-to-H exchange constant is 12.3 sec-1, nearly the 
same as A2, which nearly back-exchanges completely. K6 and K15, however, have 
exchange constants that are much closer in value (6.7 and 5.8 sec-1, respectively). 
These are on nearly the same level as M8, and faster than E12, both of which nearly 
back-exchange entirely. Therefore, we can conclude, with a fair degree of certainty, that 
K6 and possibly K15 are truly involved in a stabilizing interaction.  
 For comparison purposes, the DHX-ESI-MS process was performed at t = 0  
minutes (Figure 2.8). Uptake by ion 
follows the same general trend as the t 
= 30 minutes time point, providing 
evidence for a structured region 
between c2 and c15. While this data 
does more closely represent an early 
aggregate form than the t = 30 minutes 
experiment, it should be noted that this 
is not a ‘true’ initial time point; it is 
impossible to account for aggregation that occurs in the capillary leading to the mass 
 
Figure 2.8. The Nt17 region is structured early 
in the aggregation process. Two DHX time 
points were sampled: t = 0 (purple triangles) and 
t = 30 (green squares). No significant differences 
are observed in the retention by ion. 
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spectrometer and during the collection of ETD data. As such, it is likely that a conformer 
‘ensemble’ is again sampled; the peptide was sampled closer to the t = 5 minutes time 
point. A degree of β-sheet formation is evident in the ThT curve (Figure 2.1A). The data 
suggest that aggregates formed at earlier times are structurally similar to those 
observed to be produced from the more advanced fibrils.   
  
2.3.7 Comparison of the structural findings.   
 One of the central findings of this work is the key role of lysine residues, K6 and 
K15, in the Nt17 tract. As it has been shown that α-helical structure in Nt17 is conserved 
in oligomeric precursors to fibrils,4, 8 it is notable to consider whether or not similar 
intermolecular interactions at these two residues also play a role in oligomer formation. 
The lysine residues in question lie at the “edge” of the hydrophilic region of the 
amphipathic helix. In the arrangement of helices in the proposed tetrameric oligomer,8 
K6 and K15 could provide a tethering effect that drives formation and stabilizes the 
structure. Recent work by Michalek et al. suggests exposure of the lysine residues 
when the N-terminal domain is anchored to a lipid substrate. It is suggested that these 
residues can participate in an antiparallel interhelical dimer through K9 – E12 and K6 – 
S16.45 From these data it would appear that the K6 – S16 interaction is the most likely, 
though the c16 peptide fragment fell outside the range of our mass spectrometer.  
 Several studies have shown that two S to D mutations, which mimic 
phosporylation, in Nt17 retard aggregation.21, 22 Trypsin proteolysis of wild type peptide 
resulted in cleavage of Nt17 only at the K6 site, supporting the notion that further 
residues are protected in the fibril structure and that these residues may play a larger 
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role in promoting the formation of specific aggregate forms. Furthermore, introduction of 
the S to D mutations resulted in cleavage at K9,21 increasing solvent exposure of these 
residues. These S to D mutations could induce a critical interaction with the neighboring 
lysine residues that destabilizes precursor structure, and thus, prevents aggregation.  
 As the Nt17 domain has known lipid-binding properties,7, 14, 46, 47,11, 45 the 
availability and orientation of the Nt17 in an aggregate form could dictate if htt 
aggregates interact with subcellular membranes directly. For example, a recent study 
using htt-exon1 constructs demonstrated that pre-aggregation of a htt-exon1 protein into 
fibrils resulted in limited to no interaction with lipid bilayers,15 which suggests that the 
specific residues that facilitate lipid binding in htt are not exposed in the fibril structure. 
Although further study is warranted, these residues may also be involved in interactions 
that promote and stabilize htt aggregates in the absence of lipids.. The data presented 
in the current study, when taken in the context of previously published work on a pre-
aggregated form of the same model peptide in the presence of a lipid bilayer, suggests 
that the residues that stabilize helix-lipid interaction are unavailable at the time of 
injection onto a bilayer. It is proposed that the lack of membrane insertion observed by 
Burke et al. is due to the stabilizing charged residues being unavailable in the 
aggregated form; our data show that K6 and K15 are unavailable, and thus will not 
stabilize a lipid interaction.  
 This study represents the first time top down mass spectrometry and isotopic 
labeling has been applied to structural characterization of huntingtin peptide 
aggregates. The data show that the 17 residue N-terminal region of htt is at least 
partially solvent-exposed in the aggregated form. The experimental findings implicate 
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several hydrophilic residues in the amino terminal tract of huntingtin that could be 
involved in critical inter- or intra-molecular interactions, specifically K6 and K15. The 
data points to several novel interactions in the N-terminal domain that can be targeted in 
future chemical labeling studies, and is the first to show the importance of lysine 
residues in huntingtin aggregation. Unlike the bottom-up approach, the method outlined 
in the current study does not require time-consuming proteolysis that can lead to loss of 
site-specific information and aggregation of the analyte. Most importantly, the study 
demonstrates a viable technique application for obtaining meaningful qualitiative 
structural information on a low-resolution instrument for a relevant biophysical system 
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3. Huntingtin N-terminal monomeric and multimeric structures 
destabilized by covalent modification of heteroatomic residues1 
1Reproduced with permission from Biochemistry, submitted for publication. Arndt, J. R., 
Kondalaji S. G., Maurer, M. M., Parker A., Legleiter J., Valentine S.J.  submitted to 
Biochemistry. Unpublished work copyright 2015 American Chemical Society.  
 
 
Early-stage oligomer formation of the huntingtin protein is driven by self-
association of the seventeen-residue amphipathic α-helix at the protein’s N-
terminus (Nt17). These oligomeric structures have been implicated in neuronal 
toxicity and may represent the most neurotoxic species in Huntington’s disease. 
Therefore, a residue-specific structural characterization of Nt17 is crucial to 
understanding and potentially inhibiting oligomer formation. Native electrospray 
ion mobility spectrometry-mass spectrometry (IMS-MS) techniques and 
molecular dynamics simulations (MDS), have been applied to study coexisting 
monomer and multimer conformations of Nt17, independent of the remainder of 
huntingtin exon 1. From the MDS experiments for the dimer ions, K6 residues in 
both monomer constituents interact with S16 and E12 residues on adjacent 
peptides. Decrease in multimer formation as a function of covalent modification 
could result from disruption of this interaction. This work provides critical insight 
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3.1 Introduction: Nt17 interactions and modifications studied by IMS-MS 
 Huntington’s disease is a fatal neurodegenerative disease caused by an 
expanded, glutamine-coding CAG repeat sequence in the huntingtin gene 1.  The 
resulting expanded (>37 residue) polyglutamine (polyGln) tract in huntingtin exon 
1 is responsible for aggregation 2, 3. Directly adjacent (N-terminal) to the polyGln 
tract is a seventeen-residue amphipathic α-helix (Nt17). This tract is the driving 
force behind potentially toxic oligomer formation 4, 5, anchoring to a lipid substrate 
6-8, and cellular trafficking 9, Nt17 association is the critical first step in 
oligomerization 5. In the present work Nt17, independent of the polyGln domain, 
was used to model the earliest stages of Nt17-driven oligomer formation of the 
huntingtin protein. A motivating factor in this study is that modifications of this 
sequence at selected side-chains may be used to glean insight to inhibiting toxic 
oligomerization. To date, no study has directly probed interactions of Nt17 
monomers or downstream effects of monomer modification on multimer 
formation and structure. This study serves as a model for early stages of Nt17-
mediated huntingtin aggregate nucleation and provides insight into key residues 
in initial Nt17 association. 
 Nt17 populates multiple secondary structures, ranging from 75% random-
coil to mostly helical, depending on the buffer and proximity of binding partners 
10-12. Jayaraman et al. suggest that Nt17 adopts a helical structure only upon 
interaction with a second Nt17 tract 5. Nt17 maintains its helical structure in 
fibrillar forms of huntingtin exon 1 13, which suggests the helical conformation is 
relatively stable within the fibril. Post-translational modifications of Nt17, such as 
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phosphorylation of T3, S13 and S16, retard Nt17-mediated aggregation possibly 
by stabilizing a random coil arrangement and thus preventing formation of helical 
structure 14-16.  
 The current study demonstrates the inherent structural heterogeneity of a 
sequence that is implicated in potentially toxic oligomer formation in Huntington’s 
disease. When combined with molecular dynamics simulations (MDS), two 
monomeric structural types resembling partial helices (proposed solution 
structures) are observed. Additionally, several multimeric species are observed, 
ranging from compact globular to extended helical bundle. For dimer ions, MDS 
suggests that the most elongated, and potentially most relevant, conformation is 
an arrangement of antiparallel helices stabilized by intermolecular hydrogen 
bonding interactions. Finally, covalent modification reveals solvent accessibility of 
residues near the N-terminus of the peptide at the boundary of the hydrophobic 
and hydrophilic faces. This modification serves to destabilize multimer formation. 
This is the first instance of direct, structurally-specific, monitoring of Nt17 
oligomer formation. This model provides insights into the structural underpinnings 
of Nt17-driven huntingtin oligomerization while also providing a potential target 
for inhibition.  
 
3.2 Materials and Methods 
3.2.1 Sample Preparation. 
 Nt17 peptide was purchased as a lyophilized powder (Genscript, Inc.). 1.0 
mg of powder was dissolved in 1.0 mL of 50/50 trifluoroacetic 
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acid/hexafluoroisopropanol (TFA/HFIP) and separated into 200 µg aliquots. All 
solvent was evaporated by a stream of nitrogen, then samples were placed in a 
vacuum evaporator for three hours to create a peptide film. Films were stored at -
20°C until use. All samples were reconstituted in 0.1 M ammonium acetate 
(Fisher) to yield a final concentration of 0.2 mg mL-1. All water used was purified 
to 18.2 MΩ resistance (Millipore).  
 
3.2.2 Carbethoxylation with diethylpyrocarbonate (DEPC).  
 DEPC solutions were made by diluting stock DEPC (Thermo) into LC-MS 
grade acetonitrile (Fisher). Typically, structural analyses avoid the use of 
organics as much as possible; however, DEPC has a very low solubility in water, 
so organic solvents, in this case, were unavoidable. Freshly reconstituted 
samples were labeled at 5×, 50×, and 250× (mol DEPC:mol Nt17) 
concentrations. In each case, 1% or less (v/v) acetonitrile was added to the 
samples. Samples were allowed to react for 10 minutes before a 200 µL aliquot 
was removed for electrospray.  
 
3.2.3 Ion Mobility Spectrometry-Linear Ion Trap Mass Spectrometry (IMS-MS).  
 Samples were analyzed on a hybrid (home-built) IMS-linear ion trap (LIT) 
mass spectrometer (Thermo), which has been described in detail elsewhere 55, 56, 
as well as in Chapter 1. The ESI voltage was maintained at 1.7 kV, with a 0.5 µL 
min-1 solution flow rate. ESI emitters were pulled from untreated fused silica 
capillary. A linear voltage drop was applied along the length of the drift tube to 
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give a constant field of 1000 V m-1. Ions are trapped at the front of the drift tube 
after electrospray by an ion funnel 57, where they are introduced at 20.0 ms 
intervals. The potential on a second gate located near the drift tube exit was 
lowered to allow ions into the mass spectrometer (Thermo LTQ Velos Pro, 
Thermo Scientific, San Jose, CA). The delay between the front gate and the back 
gate is scanned to create the IMS-MS spectrum. Each mass spectrum was 
collected for 30 seconds at each delay time setting, with a 400 ms maximum ion 
trap injection time. Four microscans were averaged to generate the mobility-
resolved mass spectra. All mass spectra were collected from 150 to 2000 m/z. 
 
3.2.4 Molecular dynamics.  
MDS experiments required the construction of the [M+2H]2+ monomer and 
[M+3H]3+ dimer peptide ions.  The charge sites for these ions were selected from 
experimental mass spectra. The ε-nitrogens of residues K9 and K15 were 
protonated for the doubly-charged monomer, while both K9 residues and a single 
K15 residue were charged for the triply-charged dimer ion. Although a tentative 
selection, these residues are chosen as the charge site locations because upon 
carbethoxylation of K6, no reduction in [M+2H]2+ ion production is observed (see 
Results and Discussion). One linear starting structure was employed for each 
charge state. Each initial structure was optimized at a quantum chemical level of 
HF/6-31G(d) and used for calculating molecular electrostatic potential (MEP) 
values and charge fitting performed with the R.E.D. Server 58-61.  To generate the 
initial extended structures for MDS, the AMBER force field FF12SB was 
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employed. The method used for annealing was similar to that described 
previously 62.  Energy-minimized conformers were subjected to simulated 
annealing for 40 ps using the AMBER12 package 63.  First the conformers were 
subjected to dynamics at 1000 K.  Next, they were subjected to a gradual 
temperature gradient (to 50 K) and were subsequently energy-minimized.  For 
each ion conformer study, 1000 cycles of annealing were conducted for 40 ps 
and the final, energy-minimized structure from one cycle was subjected to 
dynamics at 1000 K for the next cycle.  The 1000 cycles of annealing were 
conducted with no non-bonded cutoffs to generate 1000 candidate structures. 
The collision cross sections of the 1000 conformers were calculated using the 
Mobcal 64 software employing the trajectory method (TM) 65.  The potential 
energies of the 1000 conformers were plotted as a function of collision cross 
section.  Matching (<1% difference in collision cross section), low-energy ion 
structures were selected for comparisons to experimental data. Structures were 
illustrated using VMD ver. 1.9.2. 
 
3.3 Results and Discussion 
3.3.1 Nt17 Adopts Several Monomeric and Multimeric Conformations.  
 IMS-MS distributions produced upon electrospray of the unlabeled sample  
are shown in Figure 3.1. Multimers up to, and including, a tetramer are observed. 
The mass spectrum is dominated by the doubly-charged monomer ([M+2H]2+) 
ions, which primarily adopt two conformations that are mobility resolved (Figure 
3.1B).  The first conformer, arriving at 11.0 ms, is of higher abundance (~4 fold)  
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than the other as demonstrated 
in the drift time distributions 
shown in Figure 3.3A. The 
second, less-intense, feature 
corresponding to doubly-charged 
monomer ions exhibits a longer 
drift time (~12.4 ms).  From 
Equation 1, collision cross 
sections for the compact and 
more elongated [M+2H]2+ ions 
are determined to be 399.8 ± 0.8 
and 442.7 ± 0.1 Å2 (see Table 1). 
At least four distinct 
dataset features corresponding 
to triply-charged dimer 
([2M+3H]3+) ions are observed in 
the two-dimensional (2D) IMS-MS datasets (Figure 3.1C).  A broad feature (tD ~1 
ms FWHM) is observed at a drift time of ~10.6 ms as shown in the 2D drift time 
distribution in Figures 3.1B – E, as well as the tD distribution in Figure 3.3.  
Narrower features are observed at tD 11.6 and 12.7 ms (Figure 3.3A). The 
dataset feature at 12.7 represents the most intense peak for the [2M+3H]3+ ions, 
 
Figure 3.1. False color IMS-MS distributions 
of Nt17 ions. Colored intensity is presented in 
log scale. All panels are represented with the 
same color scale. a.) Full IMS-MS scan with 
associated mass spectrum (left). b., c., d., and 
e.) Enhanced images of monomer, dimer, trimer, 
and tetramer structures, respectively. 
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exhibiting a peak intensity that is ~2 fold greater than the other dataset features, 
which demonstrate similar intensity levels.  A separate dataset feature  
representing a shoulder on the most intense peak is observed at a tD of 13.2 ms. 
The collision cross sections for the 
partially-resolved [2M+3H]3+ ions are 
568.1 ± 0.3, 620.3 ± 0.1, 671 ± 5, and 
708 ± 1 Å2 for the various conformations 
in order of increasing size. The broad 
feature at 10.6 ms appears in essentially 
all multimeric tD distributions, up to and 
including the tetramer (Figure 3.2). 
In each spectrum, the feature has 
the same peak shape. This may suggest 
the feature is derived from higher-order 
(n>4) multimer species that dissociate 
after the drift separation. In support of 
this argument, a calculated collision 
cross-section for a triply-charged dimer 
ion occurring at 10.6 ms is 568 Å2. This 
value is ~10% smaller than all of the 
smallest dimer configurations sampled by MDS (see 3.3.3 Conformations of  
 
Figure 3.2 – Extracted tD distributions 
for dimer (green), trimer (orange), and 
tetramer (bllue) ions. The dotted box 
shows the feature at 10.6 ms for all ions, 
suggesting that this feature arises from 
dissociation of a higher-order 
complex(es) after the drift separation. 
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Multimeric Ions results section) and matches 
closely (~2.3% larger) to a spherical compact 
arrangement 45. Early-stage oligomers would be 
expected to consist of arrangements of 
elongated helices, as observed in fibril structures 
5, 13, 66. Unfortunately, the multimer from which 
the 10.6 ms feature may have arisen is not 
distinguished in the 2D distribution and cannot 
be reliably identified.  
 Several higher-order multimeric structures 
([3M+4H]4+ and [4M+5H]5+ ions, Figures 1D and 
E) are also evident in the 2D spectrum. For the 
former ions, the same broad dataset feature 
centered at a drift time of 10.6 ms was observed 
as in the other conformations.  A narrower 
conformer with a collision cross section of 886 
Å2 is observed at a longer drift time (12.4 ms).  
For the [4M+5H]5+ ions, a broad dataset feature 
is observed to have collision cross-section of 
1073 Å2.  
 
 
Figure 3.3. Nt17 ribbon 
structures calculated from 
MDS. Pink regions are α-
helical. Blue regions correspond 
to a 3-10 helix. a.) Extracted tD 
distribution for [M+2H]2+ ions. 
b.) Compact conformer (1) at 
11.0 ms. c.) Extended 
conformer (2) at 12.4 ms. See 
Table 1 for assigned collision 
cross-sections 
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3.3.2 Compact and elongated Nt17 [M+2H]2+ Ion Structures from Molecular 
Dynamics Simulations.   
Solution studies have proposed that Nt17 exists primarily as a random coil 
in a native-like environment 13. Separate studies, both solution 67, 68 and 
simulation 12, 69, 70, have suggested the presence of helical monomers in  
solution. The IMS data presented here (Figure 3.1 and Figure 3.3) suggests the 
presence of two dominant coexisting solution structures for peptide monomers. 
 Figure 3.3A shows the tD distribution of the doubly-charged monomer. 
Figure 3.3B and C depict energy-minimized compact (Structure 1) and elongated 
(Structure 2) structures of Nt17 obtained from MDS. These structures represent 
the lowest energy conformers that are within 1% of the experimental collision 
cross-sections of the two [M+2H]2+ dataset features. It should be noted here, that 
all structures presented in the present study represent gas-phase conformations 
that best fit to experimental gas phase conformers arising from different solution 
structures 30. That is, although the monomer structures are modeled in the gas-
phase, they may not completely resemble solution conformers.  
Both monomeric conformers are mostly helical. The high degree of helical 
propensity for both structures is consistent with proposed and experimentally 
observed solution structures contained within a huntingtin peptide aggregate 13, 
69, 71. The primary difference between the compact and elongated monomer 
structures is the propensity for the random coil region (residues 11 to 17) in 
Structure 1 to turn back on itself and potentially associate with the helix (Figure 
3.3B). In the elongated structure, the portion C-terminal to the helical region is 
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extended away from the rest of the peptide. Additionally, Structure 2 contains a 
3-10 helix spanning residues A10 to E12. This helix could prohibit C-terminal 
association as is observed in Structure 1. In the Structure 1, residue K6 is in 
relative proximity to S16. Interestingly, K6 is potentially involved in intermolecular 
interaction from an early aggregate state 52. In solution, such proximity could lead 
to charge-dipole interactions between the ε-amino group on K6 and the primary 
alcohol group on S16.  Previous experiments have shown that phosphorylation 
and S16D mutations decrease aggregation kinetics through inhibition of Nt17-
driven oligomerization 14, 15. One hypothesis for the inhibition of oligomer 
formation could be a charge-charge interaction formed between K6 and residue 
S16, though the proximity could be due to charge solvation of the neighboring K9 
in the gas phase. Still, if this is reminiscent of a solution structure, this interaction 
could prevent the formation of the extended helices observed in short huntingtin 
peptide oligomers and mature huntingtin fibrils 5, 13. It is intriguing that both of 
these structures match closely to the extended solution conformer found by 
Kelley et al 71. Indeed, the calculated collision-cross section of the elongated 
structure modeled here is within ±3% of the proposed solution helix.  
 
3.3.3 Conformations of Multimeric Ions.  
Simulated annealing was performed on a dimeric species to gain some 
insight to possible gas-phase structures that arise from solution conformations. 
Figure 3.4A shows the tD distribution of all dimer species. Figure 3.4B, C, and D 
depict the results from the simulated annealing experiment (Structures 3, 4, and 
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5, respectively). Structure 3 corresponds to a dimer ion species that would have 
a tD of 11.2 ms (622 Å2), while Structures 4 and 5 depict ions that would have a tD 
of 12.6 (666.3 Å2) and 13.2 ms (709.9 Å2), respectively. Structure 3 is composed 
of two partial 3-10 helices that are arranged skew to one another, which could 
 
Figure 3.4. Nt17 dimer structures calculated from MDS. Color schemes are the same 
as in Figure 3.3 a.) Extracted arrival time distribution. ‘3’, ‘4’, and ‘5’ correspond to 
relevant dimer structures, depicted in panels b., c., and d., respectively. 
 
represent the first step in transition to structures representative of Structures 4 
and 5. The next, more elongated, conformer, Structure 4, consists of two partially 
helical monomers that are arranged offset to one another. The α-helix in one 
monomer ranges from the N-terminus to A10, where a random coil region leads 
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into a 3-10 helix. This monomer constituent resembles Structure 2. The second 
monomer exhibits two 3-10 helices: one from the N-terminus to E5, the other 
from K15 to F17. It should be stressed here that the structures obtained from 
simulation are gas-phase structures and the actual degree of similarity to solution 
structures is unknown. Still, reliable estimates of solution conformation have 
been presented from gas-phase structures 27, 30, 31. It is also noteworthy that 
elements of secondary structure similar to those found in the monomer species 
(and contained in a fibril 5, 13) are observed for the dimers. 
Structure 5 depicts a structure obtained from MDS that is consistent with 
the most elongated conformation of the Nt17 dimer. In this model, both peptides 
are partially helical, with the α-helix spanning from the N-terminus to A10 in one 
monomer, and an extended α-helix-coil-3-10 helix motif in the second monomer. 
Interestingly, the helices are arranged antiparallel to one another. K6 interactions 
stabilize the dimer structure through hydrogen bonding; at one end, K6 
associates with S16, while at the other end K6 interacts with E12. Previous 
solution docking simulations have alluded to a stabilizing K6-S16 interaction in 
antiparallel Nt17 helices 10. Additionally, solution-based deuterium exchange 
measurements revealed an increased role of K6 in Nt17 multimer structure 52. 
Finally, S13D and S16D mutations in Nt17 prevented aggregation of huntingtin 
exon 1 synthetic models via the Nt17-mediated pathway 14. The dimer 
conformations resemble the assembly of two elongated monomer structures 
(Structure 5). Considering structure comparisons above, as well as the native  
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ESI conditions, these analyses may well provide information regarding Nt17 
binding face in the earliest stages of oligomer formation. 
For the [3M+4H]4+ ions, the larger ions (Figure 3.1D) with  collision cross 
sections of  873 Å2 and 902 Å2 are ~22% and 24% larger, respectively, than 
expected values for globular structures based on a fit to experimental data 45.  
The larger ions show a percent difference that is near that (~21%) expected for 
helical bundles of this size but well below that (~51%) determined for helices 
joined end on. The calculated cross section of the elongated trimer is near that of 
insulin A chain packed as a helical bundle (874 Å2 vs. 840 Å2 for insulin A chain) 
45. The two peptides are similar in length, so similarity in gas-phase helical 
packing would be expected. The [4M+5H]5+ ion conformers (Figure 3.1E) display 
a similar trend.   The elongated (1073 Å2) ion has a collision cross section that is 
~26% larger than the expected value for a globular multimeric structure based on 
a fit to experimental data.  This value is slightly above the percent difference for 
helical bundles (~16), and well below that expected for the percent difference 
increase (~75%) for helices arranged end on. Additoinally, the calculated cross 
section of the Nt17 tetramer, 1073 Å2, is in the same range as helical bundled 
insulin A chain (approximately 1010 Å2) The lack of a polyGln domain in the 
current study should be considered. In a fibril, polyGln β-sheet structure can 
impinge upon the Nt17 region at the last two Nt17 residues 17. In the present 
study, the C-terminal portion of Nt17 are disordered, so structural transition to β-
sheet is a possibility.  
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3.3.4 Carbethoxylation Introduces a New Monomer Structure. 
 
 
Figure 3.5. tD distributions of covalently modified Nt17 [M+2H]2+ monomer at 5x 
(A), 50x (B), and 250x (C) DEPC. tD distributions are normalized to total peptide ion 
counts. Blue trace: unlabeled Nt17; green trace: singly modified Nt17; red trace: doubly 
modified. D – F, mass spectra at each DEPC concentration showing monomer m/z 
range (violet box) and dimer m/z range (gray box). 
 
Covalent modification with DEPC was performed to determine effects of charged 
side chain modification on Nt17 multimerization. Figure 3.5 shows IMS-MS 
distributions of [M+2H]2+ peptide ions at various states of modification after ten 
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minutes of incubation with DEPC (for 2D IMS-MS distributions depicting the 
course of modification, see Figures 3.6 and 3.7). Drift times and collision cross 
sections for each species are presented in Table 1.  
Speciesa m/zb td (ms)c Ω (Å2)d 
Nt17 988.1 11.2 400 ± 1 
    12.4 443 ± 1 
Nt17 x 2 1317 11.6 620 ± 1 
  12.6 671 ± 5 
  13.2 708 ± 1 
Nt17 x 3 1481 12.6 874 ± 1 
Nt17 x 4 1581 12.0 1074 ± 1 
Nt17 N/T3C 1024 11.6 413 ± 0 
  12.8 457 ± 1 
Nt17 T3C, K6C 1060 11.6 414 ± 1 
  12.2 436 ± 1 
    13.0 465 ± 1 
  
13.6 729 ± 1 
Nt17 x 2 N/T3C, K6C* 1389 13.4 718 ± 1 
Table 1. Calculated collision cross-sections for selected Nt17 modified and un-
modified conformers. a Species are identified as monomer (Nt17) with carbethoxylated 
residue identified. *Two monomer units were modified near the N-terminus, one was 
modified at K6. b measured m/z value. c measured drift time in ms. d calculated collision 
cross section with standard deviation (n = 3 replicates). 
	  
At 5× label (Figure 3.5A), two distinct unlabeled [M+2H]2+ ion conformers are 
observed as well as two distinct species for the singly-labeled ions. The 
unmodified peptide and singly-modified peptide ion conformers are observed at 
shorter and longer drift times, respectively. Doubly-modified peptide ion 
conformers are not observed in the 5× trials but were observed as significant 
species at higher label concentrations. Additionally, at the 5× label concentration, 
total monomeric peptide ions accounts for approximately 50% of the total peptide 
signal, with ~36% of the total peptide signal attributed to unlabeled monomer. 
The rest of the peptide signal is comprised of multimeric structures (see Figure 
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3.5D – F for range of dimer m/z values as well as the Supporting Information for 
modified dimer 2D IMS-MS distributions). Total dimer, trimer, and tetramer 
species comprise ~38%, ~9%, and ~3% of the total peptide signal, respectively. 
Each multimer exists in several states of covalent modification. It is noted that 
this technique is unable to determine the origin of multimers; that is, it cannot 
distinguish between species that are modified before or after association. For this 
reason, the effect of covalent modification on formation of multimeric species was 
calculated as a percent of total peptide species. 
 
Figure 3.6. 2D IMS-MS distribution showing an expanded regions of unlabeled, 
singly-, and doubly-modified Nt17 at the 5x, 50x, and 250x DEPC concentrations. 
Note the appearance of the intermediate doubly-modified species (1060 m/z, 50x and 
250x).  
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 The first modification increases the collision cross section of [M+2H]2+ 
peptide conformers by ~14 Å2 (Figure 3.5A).  Overall monomer signal increases 
at the 50× label concentration (Figure 3.5E), to approximately 66% of the total 
peptide signal. At this concentration, a second modification is evident at m/z 
1060 (Figure 3.5B and 3.6F and I). The second modification has less effect on 
collision cross section; the largest increase in collision cross section was ~7 Å2 
for the most extended conformer. Notably, a new conformer is observed at a tD of 
12.2 ms (653 Å2) in the doubly-modified [M+2H]2+ ion tD distribution. It is noted 
that the size of this is closer to the more compact arrangement (Figure 3.3B, 
Structure 2). No additional collapsed monomeric structures are observed, and 
the small amount of organic solvent added to the solution to initiate the labeling 
was not sufficient to induce denaturation of the peptide (less than 1% by volume 
for each concentration); evidence for new structures was only observed once the 
peptide was doubly modified. Under these conditions, the majority of the 
monomer signal stems from the singly modified peptide; approximately 53% of 
the total peptide signal is attributed to this species alone. Multimer signal also 
decreases, falling to ~27%, ~5%, and ~2% total dimer, trimer, and tetramer at the 
50× level, respectively.  
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Figure 3.7. 2D IMS-MS distributions of modified dimer species. The overall 
abundance of mulitmer decreases as a function of label concentration. 
 
 At the 250× label concentration (Figure 3.5C and F, 3.6G, H, and I), 
almost no residual unlabeled monomer exists. The base peak of the collapsed 
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mass spectrum is the doubly modified monomer. Total monomer increased in 
this experiment to ~89% of the total peptide signal, while dimeric, trimeric, and 
tetrameric signal dropped to ~8%, ~2%, and ~0.5%, respectively. The 
appearance of the doubly-modified monomer does correlate with a sharp decline 
in multimer formation. This suggests that the covalent modification induces 
instability in the complex leading to a shift in equilibrium to the monomeric state. 
These results could have implications in posttranslational modification studies of 
huntingtin exon 1, where modifications of hydrophilic residues have been shown 
to alter aggregation kinetics and morphologies, either by introducing a 
monomeric structural change or through inhibition of residue-specific interactions 
14-16, 72.   
 
 
3.3.5 Lysine-6 is Modified at Elevated DEPC Concentrations.  
 Figure 3.8 shows a mobility-selected MS/MS spectrum of the new, doubly 
modified, intermediate monomer conformer at 12.2 ms. The front and back gates 
in the drift tube have been set to allow only species with an arrival time 
distribution from 12.0 to 12.6 ms. Mass selection and fragmentation was 
performed in the mass spectrometer. Figure 3.8 shows the sequence coverage 
obtained with MS/MS analysis. The Nt17 peptide contains several potential sites 
of modification, including the N-terminus, and residues T3, K6, K9, S14, K15, and 
S16. Singly modified peptides from MS/MS analysis are modified either at the N-
terminus or at residue T3. Unfortunately, the b1 and b2 ions are not present in the 
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observed ion sequence; therefore, the first modification could not be 
unambiguously identified. The N-terminus would be the most likely site of  
modification, because even in an 
aggregated state, it is solvent-
exposed and heteroatom sites 
are very labile 5, 13, 52. It would 
appear that the modification of 
residues N-terminal to Leu4 does 
not introduce any structural 
rearrangement (Figure 3.5B, e, 
and h); this modification has little 
to no bearing on gas-phase 
conformation, other than a slight 
increase in collision cross-
section owing to the larger 
carbethoxy moiety.  
 At elevated DEPC 
concentrations, K6 is modified. 
MS/MS studies confirm that all 
three doubly modified 
monomeric conformers are 
modified at the same residues. 
The b7 ion is the most abundant ion in the MS/MS spectrum. Additionally, an ion 
 
Figure 3.8. Mobility selected MS/MS analysis 
of the intermediate, doubly modified 
conformer. a.) Sequence coverage by ion. b.) b-
ion series. c.) y-ion series. d.) Enhanced region 
showing the y8 ion for clarity. 
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corresponding to unmodified K6 was not observed. For these conformers, no 
other lysine residues were modified; carbethoxylation occurred exclusively on K6, 
and as such, resulted directly in the newly observed conformer at 12.2 ms 
(Figure 3.5F and I). K6 is contained within the conserved monomeric ion α-helix 
in the N-terminal portion of Nt17 from MDS (Figure 3.3B and c, Structures 1 and 
2). Additionally, MDS suggests that K6 could be directly involved in two 
stabilizing interactions in the Nt17 dimer; both E12 and S16 are potential binding 
partners for this residue. The most dramatic decrease in total mulitmer formation 
correlates with the emergence of the doubly-modified conformer at tD 12.2 ms, 
which suggests this structural transition increases destabilization of multimeric 
species, either by introducing a new intermolecular interaction that destabilizes 
the α-helix, or by preventing hydrophilic K6 interactions, such as those suggested 
by MDS.  
 
3.3.6 Interpretation of Structural Findings.  
 Simulations of pathogenic and non-pathogenic Nt17-polyQ-polyP reveal 
that Nt17 has the propensity to form helical bundles early in the aggregation 
process, with helical content increasing in the pathogenic (55Q) form 69. The 
monomeric extended helix conformer has been implicated in studies containing 
the amyloidogenic polyGln tract as the most prevalent structure, with helices 
ranging from residues 4 – 12 to 2 – 17 5, 13, 69, 71. In contrast, solid state NMR 
studies on fully aggregated Nt17Q35P10K2 showed that β-sheet character from 
the amyloid core penetrated to S16; however, helical nature was conserved over 
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the region containing K6 17. This is not out of the realm of possibility, as in light of 
the results obtained here, the random nature of the C-terminal portion of Nt17 
suggested by MDS could very easily transition to a β-sheet conformation. 
Previous simulations on the Nt17 region alone show a two-helix bundle is a 
dominant structure at room temperature; residues Met1 – Met8 are contained in 
an α-helix with a loop from residues K9 - F11 71. In the same study, a second, 
straight helix conformer is evidenced at room temperature. The current study 
provides evidence for two relevant monomeric Nt17 structures stemming from 
solution species, which are mostly consistent with the findings of Kelley et al 71. A 
strong helical propensity is observed for the first eleven N-terminal residues; 
however, where Kelley et al. demonstrate a helix-turn-helix structure, referred to 
in their work as a two-helix bundle, the current study shows that the most 
abundant ion conformer contains a helical N-terminus with a disordered C-
terminus. The second structure presented in the current study could most closely 
resemble the extended helix structure observed by Kelley et al., though they did 
not report any exivdence of a 3-10 helix. The data presented in the study by 
Kelley et al., and the work presented here, contrasts previously published work 
that states no stable helix is evident in N-terminal huntingtin monomers 5, 73. It 
should be noted that measurements in these referenced studies are based on 
circular dichroism spectropolarimetry, which only reports on average 
characteristics. It was assumed that α-helix character was a result of transient 
oligomers present in solution upon reconstitution. In light of the data presented 
here, this conclusion may be cursory, as both the matching monomeric and 
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multimeric MDS conformations contain a degree of helicity. Indeed, crystal 
structures of huntingtin model peptides with an extended polyGln tract show a 
large amount of helicity in the Nt17 region 68.  
 Trimeric and tetrameric species have been observed that appear to have 
conformers similar in size to bundles of elongated helices 45. These structural 
assignments are in good agreement with prior work that states Nt17 associates 
via α-helical interactions and maintains its helical nature in mature amyloid fibrils 
5, 13, 17, 71. Because the data in the current study seem to indicate that elongated, 
helical, structures are conserved in the gas phase, it is noted that the elongated 
trimer and tetramer conformers observed here are assumed to contain a degree 
of helicity. This can also be argued due to the nature of Nt17 to form extended 
helices in amyloid fibrils and the similarity of collision cross sections to calculated 
helical bundle peptides of similar length.   
  
3.3.7 Covalent Modifications Alter Structures.  
 Multiple PTM’s have been implicated in accelerating or inhibiting 
huntingtin exon 1 aggregation 14-16, 74, 75. Phosphorylation of T3 leads to 
decreased toxicity but increased aggregation rates 16. Carbethoxylation of 
heteroatoms, while not a physiological PTM, is a means to increase 
hydrophobicity and introduces steric hindrance in the helical region. Excess of 
label reagent can destabilize secondary structures 54. Previous studies have 
used carbethoxylation by DEPC as a means to probe solvent accessibility 49, 50, 
54. Mendoza et al. use the reagent to track lysine, threonine, and histidine 
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residues in isoforms of β2 microglobulin 49, 50. In the present work, however, the 
modification of a single, hydrophilic residue led to a new monomer conformer and 
in concert, reduced overall multimerization. This occurs with a decrease in the 
elongated monomer conformer. The total contribution of the elongated conformer 
drops from 10% to approximately 7% as the new conformer appears. This may 
suggest that this conformer arises mainly from the elongated conformer, even 
though the majority of the doubly modified conformer still exists primarily in a 
compact conformation.  
 Previous work highlights the importance of K6 and its protection from an 
aggregated state in a huntingtin exon 1 model, indicating that K6 is involved in a 
stabilizing intra- or intermolecular interaction 52. In previous studies, which utilized 
top-down deuterium exchange techniques, it was not possible to determine the 
exact origin of monomeric peptide. Results from the present study suggest that 
K6 is available in a monomeric state and may be involved in stabilizing multimer 
interactions, which would account for previous reports of decreased accessibility 
52. Modification of K6 in the peptide’s multimeric state could reduce stabilizing 
interactions, and as a result, favor dissociation of the multimer species. 
Additionally, the modification could present a monomer structure that is not 
amenable for interaction mediated through K6 due to altered intramolecular 
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3.3.8 Implication of New Monomeric Structure. 
 In some cases, post-translational modification can have accelerating 
effects on multimerization. For instance, phosphorylation of T3 in huntingtin exon 
1 increased aggregation rate, as well as toxicity, in Drosophila models; Aiken et 
al. show that T3 phosphorylation occurs in vivo and may represent a therapeutic 
strategy for Huntington’s disease remediation 16. Two explanations for 
neuroprotection are proposed. Increased hydrophobicity of T3 due to 
modification either increases the rate of aggregation through the more toxic 
oligomeric state, thus reducing the amount of available toxic oligomer and 
leading to the neuroprotective fibrillar form. Conversely, modification of T3 
destabilizes helical propensity and intermolecular association, thus preventing an 
oligomeric state to form entirely, leading to formation of fibrils that are not 
mediated through an oligomeric precursor. It should be noted that K6 lies on the 
boundary of the hydrophilic and hydrophobic faces, so the interpretation provided 
by Aiken et al. for T3 could also be extended to K6. That is, the data in the 
current study would suggest that the latter interpretation for neuroprotection 
proposed by Aiken et al.; an altered helix state does not allow for extended Nt17 
multimers to form, promoting aggregation via a pathway that is not modulated by 
Nt17. Additionally, the T3 modification itself destabilizes quaternary arrangement 
leading to dissociation of multimer species. Since the model in the current study 
did not contain a polyGln tract, no comment on fibril formation can be made, nor 
can any conclusion be drawn regarding the effects of β-sheet formation in Nt17 
as a result of extended polyGln segments; however, it can be concluded that 
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modification of Nt17 at a critical boundary lysine residue reduces multimerization, 
which could lead to altered aggregation pathways. 
 Multiple studies have reported on the propensity of Nt17 to form an α-helix 
upon association with another Nt17 tract 5, 13 or a lipid bilayer 7, 76. Solid state 
NMR studies have shown that Nt17 is mostly helical in amyloid fibrils and retains 
its helicity even after advanced fibrillization, and that helicity increases with 
increased association 13, 17. Indeed, formation of an amphipathic α-helix is a 
critical step in exon 1 nucleation 5, 44, 67. Tam et al. have shown that an 
amphipathic helix from residues 4 – 12 are necessary for advanced huntingtin 
fibrillization, which represents a more extended helix 67. In the present study, a 
large portion of the monomer conformation appears to exist in an extended 
helical state in the gas phase and, upon labeling, is destabilized. It would appear 
that antiparallel association (Figure 3C) of pre-elongated peptides is possible; 
however, it is unclear which (if either) conformation is the most disease-relevant. 
One interpretation is that destabilization of the pre-existing helix abrogates 
bundled multimer structure formation that resembles Nt17 nucleation in full-
length huntingtin exon 1. It could be that the more compact monomer conformer 
may not contribute as significantly to Nt17-mediated nucleation as the extended 
state due to the C-terminal coil region folding back into, and potentially 
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3.3.9 Implication of Lysine Modification.  
 Depletion of the most elongated dimer conformers was observed upon 
modification of K6, which implies that K6 could be involved in more elongated 
helical associations of Nt17. Additionally, simulations of gas-phase dimer 
interactions show the involvement of K6 in stabilizing hydrogen bond interactions 
with oxygen-containing residues. Multiple solution simulations show that K6 is 
contained in the helical portion of Nt17, whether in its monomeric form 17, 69 or 
bound to a lipid substrate 6, 7, 76. While the current study did not probe 
aggregation kinetics, the study does suggest that modifying the ε-amino group on 
K6 inhibits inter-helical association. Modification of both the N-terminal residue 
and K6 could work synergistically, by introducing steric hindrances that prohibit 
association and by altering secondary structure, to reduce multimer formation. 
Currently, it is not clear as to the mechanism of inhibition; however, K6 appears 
to be critical in Nt17 association.  
 Huntingtin Nt17 peptide monomer and multimer structures have been 
analyzed by IMS-MS and MDS. Direct observation of monomer structure reveals 
two populated solution states that correlate well with prior simulation and 
experiment, both of which could contain partial α-helices. Several multimeric 
conformations are also observed, particularly for the dimer structure, each 
containing a degree of helicity. The most elongated dimer structure may consist 
of an arrangement of antiparallel α helices, and could be the most disease-
relevant conformation. This arrangement most closely resembles association of 
Nt17 in full-length huntingtin exon 1. MDS revealed intermolecular association in 
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the elongated dimer ions is stabilized through K6-E12 and K6-S16 hydrogen 
bond interactions. Carbethoxylation of an N-terminal residue and K6 may 
destabilize the helical structure as a new compact conformer is observed in the 
doubly-modified spectrum. Additionally, this modification drastically reduced 
multimer formation, which may suggest the critical role of K6 in the earliest 
stages of Nt17-mediated huntingtin exon 1 aggregation.  
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4. Polyproline peptides interact with Nt17 and suppress 
huntingtin aggregation  
 
The peptide representing the Nt17 region of htt has been shown in previous 
chapters to form stable elongated homodimeric and homomultimeric complexes 
in the gas phase. Association appears to be predicated on the ability of Nt17 to 
form an extended amphipathic α-helix. The C-terminal proline-rich region of htt 
exon 1 could possibly serve as a regulator of Nt17 in native htt exon 1; this 
interaction is disrupted due to a gain of rigidity in extended disease-length polyQ 
regions.1 The exact mechanism of Nt17 regulation by polyP is not well 
understood. Additionally, since polyP may act as a stabilizer of Nt17 in native htt, 
a co-incubation of disease-length htt exon 1 with a polyP peptide could have an 
impact on aggregation kinetics, morphology, or both, through interaction with 
Nt17. The work described in this chapter explores Nt17-polyP interactions 
through IMS-MS coupled to gas-phase HDX and MDS. A morphological effect of 
co-incubation is demonstrated by AFM. The results of this study indicate that 
polyP may regulate Nt17 by stabilizing a random coil region after residue M8 in 
Nt17, thus, not allowing the transition to the reactive amphipathic α-helix. 
 
4.1 Introduction: PolyP as a regulator of Nt17 
 Nt17 modulates oligomerization of htt exon 1, in bulk solution and in the 
presence of a lipid bilayer.2-4 Several studies have sought to block Nt17 self-
interaction as a means of preventing amyloid formation, or have shown that 
chemical modification results in aggregation pathways that may not Nt17-
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mediated and bypass the oligomeric state.5-8 One hypothesis suggests that the 
PolyP PPII helix acts as an intrinsic regulator for Nt17, and at sufficient PolyQ 
lengths, this interaction becomes less favorable due to induced β-turn strand 
structure in polyQ.1 A gain of structure, and thus, rigidity, in the polyQ region 
increases the intermolecular distance between Nt17 and PolyP, thus freeing Nt17 
for disease-related interaction, such as association with other Nt17 tracts or 
interaction with cellular surfaces.1 Additionally, the polyP region could act 
synergistically with Nt17 to decrease solubility of the polyQ tract and thus, drive 
aggregation.9, 10 Similarly, recent studies show that an Nt17 peptide co-incubated 
with an htt exon 1 peptide mimic was sufficient to force aggregation via a 
pathway not mediated by Nt17.5 It stands to reason, then, that like an Nt17 
peptide, a polyP peptide could interact with Nt17 and perhaps modify 
aggregation, or at least promote a pathway that is not mediated by Nt17. To date, 
no technique has directly probed residue-specific Nt17-polyP interactions, nor 
has a structural model for interaction been proposed. The information gained by 
studying this interaction could lead to valuable insight to an important active 
region for Nt17-Nt17 association, and by extension, provide a new structural 
target for disease amelioration. This study uses hybrid ion mobility-mass 
spectrometry (IMS-MS) coupled to gas-phase hydrogen-deuterium exchange 
(HDX) to probe the interactions between Nt17 and polyP in the context of 
regulating Nt17 reactivity toward mediating aggregation. 
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 Nt17 is a strong promoter of both oligomer formation and amyloid 
formation;3, 4, 10 however, the location and extent of helicity in Nt17 is not well 
defined. In x-ray crystal structures of htt exon 1, Nt17 is entirely helical with the α-
helix extending into the polyQ region.11 In other solid state NMR and simulation 
experiments, the helix is not present in the monomeric form, but rather forms a 
helix when in proximity with a binding partner, such as a second Nt17 sequence 
or a lipid bilayer.12-14 In other cases, Nt17 is tightly associated with the polyQ 
region in a monomeric form.10 In any case, it appears that Nt17 is mostly helical 
in amyloid fibrils;4, 14, 15 thus, it represents an intriguing structural target for the 
amelioration of HD progression. Several studies have modified Nt17 through S to 
D mutation, which mimics phosphorylation, at serines 13 and 16.7, 16 These 
mutations slowed the progression of Nt17-mediated htt aggregation, but did not 
prevent aggregation all together. While the goal of these studies were to examine 
the role of post-translational modification on aggregation, they did provide a 
framework for targeting Nt17. Similarly, Nt17 attached to a pathogenic polyQ 
tract has been targeted with a simple Nt17 peptide5 or by elimination by 
enzymatic digestion.3 This study showed a net decrease in aggregation, most 
likely due to Nt17-Nt17 interactions where the non-pathogenic fragment is 
included in the nucleation of pathogenic peptides, increasing the distance 
between polyQ fragments and thus, increasing the energy barrier required for 
amyloid formation. A similar idea, then, is to target the Nt17 region using another 
peptide. Ideally, this peptide would function the same as the Nt17 peptide alone 
in inhibiting nucleated amyloid formation.  
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 Previous work has shown that, in its native form, Nt17 may be stabilized 
by the polyP region, for non-pathogenic Q-lengths.1 At disease-length polyQ 
tracts, the polyQ region gains rigidity through β-sheet formation and increases 
the intermolecular distance between Nt17 and polyP, thus allowing Nt17 to 
mediate fibril nucleation; however, the structural mechanism by which polyP 
stabilizes Nt17 is unknown. The interaction could be modulated through S13 and 
S16, as phosphomimicry and true phosphorylation both showed an increase in 
intermolecular distance.1 Using IMS-MS, the current study aims to gain insight 
into the Nt17-polyP interactions and determine if polyP is a suitable inhibitor of htt 
exon 1 aggregation, much like co-incubation with other peptides that target Nt17. 
 
4.2 Materials and Methods 
4.2.1 Sample Preparation.   
 Nt17 (MATLEKLMKAFESLKSF) and polyP (Ac-P10-NH2) peptides were 
prepared according to established protocols,17 as described in Chapters 2 and 3. 
All samples were reconstituted in 500 µL of 0.200 M ammonium acetate (Fisher 
Scientific) in 18 MΩ water, purified using a Milli-Q purification system (Millipore). 
For binary samples, the first peptide was reconstituted, incubated, and vortexed. 
The resulting solution was then removed from the tube and used to reconstitute 
the second peptide film. 
 
4.2.2 Ion Mobility – Mass Spectrometry.   
 Ion Mobility – Mass Spectrometry (IMS-MS) was performed on a home-
built hybrid instrument that consists of a linear drift tube coupled to a Thermo 
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LTQ Velos Pro (Thermo Scientific, San Jose, CA). Design, operation, and figures 
of merit for the instrument have been described elsewhere, and in Chapter 1.18 
All samples were introduced at 0.5 µL/min. Ions were pulsed into the drift tube 
every 20 ms using a 150 µs pulse width. The time-delayed gate at the rear of the 
drift tube just before the mass spectrometer, was periodically lowered for 150 µs 
at a rate of 50 Hz. The delay between the front and rear gates is scanned to 
produce the drift spectrum. Ions whose drift times are equal to the delay time are 
allowed to enter the mass spectrometer. The pressure in the drift tube was 
maintained at approximately 2.6Torr. The ion trap MS was set to scan every 400 
µs, and average every four microscans.  Each mass spectrum in the drift tube 
experiment was collected for thirty seconds.  
 
4.2.3 Complex Energetics.   
 Collision-induced dissociation (CID) was used to determine relative 
complex strength for each Nt17-PolyP multimer conformation. For comparison, 
Nt17 homodimer conformations were also sampled. Conformers were drift-
selected using the IMS. Gate timing was set in order to sample the entire peak. 
Mass selection and fragmentation was then performed in the mass spectrometer. 
Helium was used as the collision gas. The parent ion signal for the complex was 
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4.2.4 Gas-phase Hydrogen-Deuterium Exchange (GP-HDX).   
 Gaseous D2O was introduced to the drift tube buffer gas to determine 
accessible sites to decipher protection as a result of non-covalent interaction, 
and to probe the most accessible sites in the complex, as described in Chapter 1. 
Liquid D2O was measured into a stainless steel bulb, sealed with a Swagelok 
fitting, and flash frozen using liquid nitrogen. The headspace above the D2O was 
pumped away, leaving only D2O in the bulb. D2O was allowed into the drift tube 
using a bleed valve. The partial pressure of D2O for all experiments was 0.01 
Torr. The helium pressure was adjusted to compensate for the addition of D2O, in 
order to maintain a total pressure of 2.61 Torr. This is a sufficient amount of the 
reagent to induce labeling of rapidly exchanging sites; in this manner, only the 
most accessible sites are labeled.  
 
4.2.5 Molecular Dynamics Simulations.  
 Molecular dynamics simulations (MD) and simulated annealing were 
performed as described in Chapter 3, using the same force field and molecular 
constraints. PolyP was constrained to an all trans conformation in AMBER by 
limiting the ω angle to between 150° and 210°. An all-trans proline conformation 
was chosen because polyP tracts favor all-trans PPII helices in aqueous 
solvents,19 and the polyP tract in htt exon 1 forms a PPII-helix.20, 21 Simulated 
annealing was performed as described previously in Chapter 3 for two different 
starting structures. The lowest energy conformations within ±1% of the measured 
CCS were examined using a hydrogen accessibility scoring (HAS) model.22 
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4.2.6. Hydrogen accessibility scoring and kinetics model.  
 Hydrogen accessibility scoring (HAS) was performed for each structure 
according to methods developed in the Valentine lab.22 This algorithm was used 
to validate the candidate structures based on the measured deuterium uptake. 
To calculate the HAS, each carbonyl oxygen within 7Å of a charge site, scaled as 
the inverse distance to the charge site (dO-N) was scored (SO). This is the HDX-
active carbonyl that initiates deuterium exchange. In the event multiple charge 
sites were within the proximity of a carbonyl, the oxygen was scored as the sum 
of inverse distances. Next, each heteroatomic hydrogen within 7Å of the active 
carbonyl was scored as: 
 
           𝑆! =
!!
!!!!
     4.1, 
 
where SH is the hydrogen score and dH-O is the interatomic distance between the 
hydrogen and the HDX active carbonyl. The residue score (SR) was determined 
using Equation 4.2: 
 
     𝑆! = 𝑆!     4.2. 
 
Solvent accessibility was also assessed in silico by allowing a water molecue to 
sample the entire peptide’s surface to obtain an excluded volume. The solvent 
accessibility and the HAS were weighted equally in calculations of exchange 
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= 𝑒!!!!                             4.4. 
 
The rate constant k is estimated using values recorded for positively charged 
peptide ions.22, 23 In Equation 4.3, A/A0 represents the fraction of sites that do not 
exchange at a given time ti. Fractions altered were compared to a ratio of a 
random number to total possible random numbers generated. If the ratio was 
less than the fraction altered, then an exchange event was recorded for the 
exchange site. The process was repeated as the ion stepped through the time 
increment (ti) up to the final drift time. 
  
4.2.7 Purification of htt exon 1 construct.   
 Disease-length (51Q) htt exon 1 was purified from Escherichia coli 
according to previously published protocols.17, 24 Briefly, pelleted E. coli colonies 
containing glutathione S-transferase (GST) fused htt exon 1 were thawed and 
resuspended in a pH 8 phosphate buffer containing EDTA and a protease 
inhibitor cocktail. The suspension was lysed using lysozyme and mechanical 
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sonication. The resulting slurry was centrifuged at 3500 RPM to pellet cellular 
debris. The solution containing the protein of interest was decanted and diluted 
1:1 into the same phosphate buffer. Proteins were purified using a Biorad 
Profinity 5 mL GST affinity column by FPLC (Biorad Prologic). Fractions 
containing protein of interest were dialyzed against a Tris-NaCl solution 
overnight. GST was cleaved from htt exon 1 using Factor Xa (Thermo). Overall 
protein concentration was determined by a Bradford assay. The final working 
concentration of htt exon 1 was adjusted to 20 µM in a Tris-NaCl buffer. 
 
4.2.8 Atomic Force Microscopy.   
 The purified GST protein and co-incubated peptides were maintained at 
37oC in Eppendorf tubes and 1400 rpm for the duration of the experiment in an 
orbital mixer. At 24 h after cleavage of GST with factor Xa protease, a 5.0 µL 
aliquot of each protein incubation was spotted onto a freshly cleaved mica 
substrate (Ted Pella Inc., Redding, CA), for 30 seconds, washed with 200µμl of 
ultra-pure water to remove salt and dried gently with a stream of clean air. The 
mica was placed on metal pucks and stored in a covered petri dish until imaging.  
 AFM imaging Experiments were performed with a Nanoscope V Multi-
Mode scanning probe microscope (Veeco, Santa Barbara,CA) equipped with a 
closed loop vertical engage J-scanner. All images were acquired with diving 
board shaped silicon-oxide cantilevers with a nominal spring constant of 40 N/m 
and resonance frequency of about ~300 kHz. Scan rates were set at 1–2 Hz with 
cantilever drive frequencies 10% below resonance. 
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4.3 Results and Discussion 
4.3.1 Nt17 and polyP form two stable heterodimeric complex conformers.  
 Nt17 and polyP were incubated together in an ammonium acetate buffer 
at a pH of approximately 7.0. The mass spectrum was dominated by the 
[M+2H]2+ Nt17 monomer, as well as the PolyP monomer of the same charge; 
however, several dimeric species were also present, including but not limited to, 
the Nt17 homodimer ([M+3H]3+) and a Nt17-PolyP heterodimer ([M+3H]3+). Other 
multimers, such as the Nt17 homotrimer and the homotetramer were observed, 
but did not decrease in abundance in the presence of the PolyP peptide. 
Additionally, a PolyP homomultimer was not observed, nor was any evidence of 
higher charge heteromultimers (e.g., Nt17-PolyP [M+4H]4+) observed. Only the 
heterodimer species was observed. All collision cross sections can be found in 
Table 1.  
 Figure 4.1 shows expanded regions of representative IMS-MS 
distributions of a co-incubated Nt17-polyP sample. Figure 1A depicts the 
structural heterogeneity of the Nt17-PolyP heterodimer. Two distinct multimer 
structures that persist in the gas phase (1002.4 m/z) are evident in the 
distribution. The origin of these complexes could stem from non-helical (compact, 
shorter drift time) and helical (elongated, longer drift time) association of Nt17 
with PolyP, or PolyP association with the Nt17 helix via two separate faces. The 
more compact conformer is roughly 20% more abundant than its more elongated 
counterpart. The first conformer has a peak centered at 9.0 ms, with a peak width 
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of 0.2 ms (FWHM). This arrival time corresponds to a collision cross section of 
539 ± 1 Å2.  
 Though distinct, the peak is not 
fully resolved from the more elongated 
conformer. It is difficult to determine if a 
third structure is present in the tD space 
between the two conformations due to 
significant overlap; however later 
deuterium exchange experiments 
suggest that these are the only two 
conformer types of this species (see 
Figure 3). The second, more elongated 
conformation had an arrival time 
centered at 9.4 ms, with a calculated 
cross section of 565 ± 1 Å2. Each 
conformation was drift-selected in the 
IMS drift tube, then mass selected in the 
mass analyzer before being subjected to 
increasing normalized collision energy. In 
this manner, we determined that the two 
conformations do not differ significantly 
in complex strength (Figure 2B); each 
conformer required approximately 15 
 
Figure 4.1. Expanded Regions of 
Representative IMS-MS distributions. 
A, distribution of the Nt17-PolyP 
[M+3H]3+ heterodimers. B, distribution of 
the [M+2H]2+ Nt17 monomer. C, 
distribution of the [M+2H]2+ PolyP 
monomer. Each panel is shown over the 
entire drift time range. 
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normalized collision energy (NCE) for 50% signal decay. This may suggest that 
the two conformers are bound similarly, perhaps including the same amino acid 
residues.  
 Several conformations of monomeric Nt17 and PolyP were apparent from 
the same mass spectrometry experiments in which the heterodimeric conformers 
were observed (Figure 1B and C). MDS suggests that the two most abundant 
Nt17 conformations can be represented by a semi-helical random structure (10.0 
ms) and an elongated, mostly helical structure (11.2 ms). These conformations 
are in good agreement with previous reports that indicate structural heterogeneity 
in the gas phase (see Chapter 3). The other two monomeric structures (8.0 ms 
and 9.4 ms) are dissociation products from higher order multimers. For example, 
the conformer arriving at 9.4 ms is most likely due to dissociation of the Nt17-
PolyP heterodimer complex at the same drift time. Analysis of the isotopic 
envelope indicated that no multimers with number of monomer units/charge (n/z) 
=1/2 (e.g., [2M+4H]4+, which would have the same m/z as [M+2H]2+) were 
present in the sample. The more elongated conformer is roughly one-tenth the 
abundance of the more compact structure, indicating that solution structure 
giving rise to the more compact structure is the dominant motif. The presence of 
both conformations suggests an equilibrium between species. The same 
argument can be applied to the PolyP peptide. Figure 1C shows the drift 
distribution of the PolyP [M+2H]2+ peptide. Both observed conformers are on the 
same cross section order as other gas-phase PolyP peptides of similar length, 
which were identified as mostly PPII helices with one or two residues exhibiting 
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residual cis PPI structure.19 The first, most compact, conformation has a drift time 
of 6.2 ms. The second, more elongated conformer has a drift time of 7.0 ms, 
which corresponds to a gas phase cross section of 276 ± 3 Å2. As with the Nt17 
monomer, no evidence of any isobaric homomultimeric species was observed. 
 
Speciesa Charge Stateb Drift Time (ms)c Cross Section (Å2)d 
Nt17 [M+2H]2+ 10.0 401 ± 1 
  11.2 443 ± 2 
PolyP [M+2H]2+ 7.0 276 ± 3 
Nt17-PolyP [M+3H]3+ 9.0 539 ± 1 
  9.4 565 ± 1 
Table 4.1. Calculated Collision Cross Sections for All Relevant Species. a Species 
name as it is referred to in the body of the manuscript and in Figure 1. b Charge state 
determined by peak spacing in isotopic envelope for drift-selected species. c Drift time 
determined by peak center in the IMS-MS distribution. See Figure 1 for IMS-MS heat 
map. d Gas-phase collision cross section determined by Equations 1 and 2 using 
experimental values.  
 
 Two Nt17-PolyP heterodimer conformations were observed. In an attempt  
to discern details beyond gas-phase cross section, each conformer was mobility 
selected using the ion mobility separation, then subsequently mass-selected and 
fragmented in the mass spectrometer. The abundance of the parent ion was 
monitored as a function of normalized collision energy. It should be noted that in 
this study, we used helium for the collision gas in the linear ion trap. Typically, a 
less polarizable gas, such as argon, is used for such studies if thermodynamics 
are to be directly calculated;25, 26 however, in this case, only a relative  
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comparison of strength is necessary. 
Thus, the use of helium gas is 
acceptable for this study.   
 Figure 4.2A and B show the 
extracted drift time distribution of the 
Nt17-polyP heterodimer and the 
relative strength of each conformer. 
The conformers do not differ in 
dissociation energy; both conformers 
have a 50% signal decay occurring at 
roughly 15 NCE, which would 
indicate that both complexes are 
energetically similar (Figue 4.2B). 
Nt17 homodimer dissociation (Figure 
4.2C) shows dissociation at 
approximately 20 NCE. Interestingly, 
the more elongated Nt17 homodimer 
conformer (filled diamonds, Figure 
4.2C) forms a slightly stronger 
complex than the more compact 
conformer (filled squares, Figure 
4.2C). In general, however, both 
Nt17-polyP heterodimers are not as 
 
Figure 4.2. Nt17-PolyP heterodimer 
energetics. A, arrival time distribution of the 
heterodimer species, with labeled conformers 
‘a’ (9.0 ms) and ‘b’ (9.4 ms). B, normalized ion 
signal as a function of normalized collision 
energy for each heterodimer conformer. 
Circles: conformer ‘a’. Triangles: conformer 
‘b’. C normalized ion signal as a function of 
normalized collision energy for two elongated 
Nt17 homodimer conformers. 
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energetically stable as the Nt17 homodimers. It should be noted that from these 
experiments, it is impossible to tell where exactly intermolecular interactions 
occur for the peptide multimers. The energetics of association can have 
implication in normal function of the huntingtin protein overall. If the polyP region 
does, in fact, regulate the function of Nt17 as suggested by Truant and co-
workers,1 then one would expect a relatively weak interaction such that Nt17 can 
undergo its normal function. Additionally, the relative strength of the homodimeric 
Nt17 complex suggests a greater affinity for itself over a small molecule binding 
partner, which is not surprising considering its potential role in aggregation.3, 4, 9, 
27  
 
4.3.2 Heterodimer conformations vary in deuterium uptake. 
 Following the evidence of two heterodimeric species, gas-phase 
hydrogen-deuterium exchange (HDX) was performed to determine differences in  
deuterium uptake by conformer. By extension, deuterium uptake may help 
determine sites of binding and provide insight into the location of exchange sites 
in the proximity of charge sites. An explanation of the gas-phase HDX 
mechanism can be found in Chapter 1, Section 1.6.3. 
 Figure 4.3 shows IMS-MS distributions for the Nt17-polyP heterodimer 
(panel A), the Nt17 monomer (panel B), and the polyP monomer (panel C). Each 
of these species are the same as in Figure 4.1A – C. Overall, very little deviation 
in drift time was observed for all species; a 0.2 ms shift to higher drift times was  
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observed, which is expected when 
using a heterogeneous drift gas 
mixture of larger gas size and mass.28  
 A surprising result is the 
differential deuterium uptake 
exhibited by the two Nt17-PolyP 
heterodimer conformations (Figure 
4.3A and Figure 4.4). The more 
compact conformation (conformer ‘a’) 
shifted upward in m/z by 1.6, which 
leads to an average uptake of 4 ± 2 
deuterium (see Figure 4 for total 
deuterium uptake). Conversely, 
conformer ‘b’ incorporated an 
average of 10.8 ± 0.5 deuterium, over 
twice the uptake of conformer ‘a’. 
Both Nt17 monomer conformations 
exhibited the same uptake of 
approximately 13 deuterium atoms, 
which is higher than that of the 
complex, indicating several 
hydrophilic residues may be involved in binding. Finally, the PolyP peptide only 
exhibited an uptake of 2 deuterium atoms. Since PolyP does not contain  
 
Figure 4.3. Deuterated IMS-MS 
distributions. A, deuterated [M+2H]2+ 
Nt17-PolyP heterodimer complex. 
Conformers ‘a’ and ‘b’ are labeled the same 
as they are in Figure 2. B, deuterated 
[M+2H]2+ Nt17 monomer. C, deuterated  
[M+2H]2+ PolyP monomer. Each panel is 
shown over the entire drift range. 
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exchangeable backbone 
amide hydrogens, these two 
deuterium atoms found in the 
PolyP tract must result from 
charge site deuteration;29, 30 
once the deuteron is 
transferred to the charge site, 
it cannot be redistributed as it 
is in peptides containing other 
labile heteroatom sites. The 
disparate uptake data may 
indicate that polyP can 
associate with multiple faces 
of Nt17, perhaps via similar interactions; however, one site provides more access 
to labile heteroatoms than does the other. Conversely, polyP could be associated 
in roughly the same place in both structures, but Nt17 could sample several 
conformations. Serines 13 and 16 have been implicated in Nt17-polyP 
interactions.1 Both S13E/S16E mutations and Nt17 hyperphosphorylation (M8P) 
by IKK kinase inhibition resulted in reduced Nt17-polyP interaction for pathogenic 
and non-pathogenic htt exon 1.1 When taken with the HDX data reported here, it 
seems the more compact conformation, which has less deuterium incorporation 
than its more elongated counterpart, could include a S13/16-polyP interaction.  
 
 
Figure 4.4. Deuterium uptake by species. 
Calculated deuterium uptake for species 
highlighted in Figure 3. PolyP: polyproline peptide 
[M+H]2+. Nt17a and Nt17b: Nt17 peptide [M+2H]2+ at 
10.6 and 11.6 ms, respectively. N-Pa and N-Pb: 
Nt17-PolyP heterodimer complex [M+3H]3+ at 9.2 
and 9.8 ms, respectively. Two asterisks denotes 
highly significant statistical difference (p < 0.01) 
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4.3.3 Gas-phase Nt17-polyP 
heterodimer structure.  
 Figure 4.5 shows the 
lowest energy conformations 
within ±1% of the measured 
CCS (found in Table 4.1) from 
MDS. Panel A represents a 
compact conformer (‘a’ in 
Figures 4.1 – 4.4), and panel B 
represents a more elongated 
conformer (‘b’ in Figures 4.1 – 
4.4). Both conformers exhibit a 
surprising lack of extended α-
helicity in Nt17. The polyP 
constituent in the compact 
conformer associates with 
Nt17 mostly by the latter half 
(M8 – S16) of the peptide. While there is some small degree of helicity from 
residues A2 to E5, the extended helix that was prevalent in the homodimeric 
complex, as well as monomeric Nt17 was not evident. Hydrophilic residues are 
buried either in intramolecular association (K6) or buried in the interaction with 
the polyP tract (K9, K15). The inaccessibility of these residues would explain the 
 
Figure 4.5. Nt17-polyP heterodimer gas-phase 
structures. A. Compact conformer, labeled ‘a’ in 
Figures 4.1 – 4.4. B. Elongated conformer, labeled 
‘b’ in Figures 4.1 – 4.4. 
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lack of deuterium uptake in conformer ‘a’ (see Figure 4.3 and 4.4). Since the 
charges are either buried or otherwise  
inaccessible to collisions with deuterium which initiate the relay exchange 
mechanism, deuterium exchange cannot efficiently proceed. The charged polyP 
C-terminus self-solvates and thus, is not highly accessible (right portion of panel 
A, white backbone region), thus not interacting with Nt17. This is an important 
point, because in a htt exon 1 context, the PPII helix would not be charged.  
 Figure 4.5B shows the more elongated conformer. In contrast to Figure 
4.5A, this conformation shows a more extended Nt17 constituent. In this model, 
hydrophilic residues K6 and K9 are solvent-exposed, which would lead to a 
greater deuterium uptake, as shown in Figures 4.3 and 4.4. Additionally, residue 
M8 on Nt17 was pointed away from the polyP tract, as opposed to potentially 
interacting with polyP in the more compact state. The same helical content was 
observed in the elongated conformer as was in the compact conformer, though 
the C-terminal portion of Nt17 did not turn back on itself, as was evident in the 
compact conformation. Lastly, it appears that in this arrangement, the polyP tract 
is oriented almost around Nt17, with hydrogens on S13 and S16 within H-bond 
distance of a backbone carbonyl on polyP. To verify the structures, HAS and 
surface accessability were incorporated into exchange kinetics and deuterium 
uptake was calculated for each candidate structure. The most compact candidate 
structure was indeed calculated to exchange on average 4.5 deuterium atoms, 
while the more elongated candidate structure should exchange roughly 9.2 
deuterium atoms. These calculated values are in good agreement with actual 
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gas-phase deuterium uptake measurements, thus, these are highly plausible 
gas-phase structures. It must be stressed here that these are gas-phase 
structures, and may be reminiscent of condensed-phase structure. These are 
structures that most closely represent the measured CCS and deuterium uptake 
patterns; however, that is not to say that the gas-phase conformations shown 
here and in other works19, 31-35 are completely erroneous. On the contrary, these 
are gas-phase structures that are reminiscent of solution-phase conformations 
that retain structural heterogeneity when transitioning into the gas-phase.  
 Two striking similarities appear upon inspection of the structures reported 
in Figure 4.5A and B. First is the lack of the extended helical conformation in 
Nt17. In solution, the Nt17 tract, both in the context of polyQ and without, adopts 
a helical conformation when in proximity of a binding partner: either another Nt17 
tract4, 14 or a lipid bilayer.12, 36, 37 Additionally, the helical association could be the 
driving force for oligomerization in htt exon 1.4, 5 The lack of extended helix 
observed here could have implications in intrinsic polyP regulation of Nt17.1 The 
polyP region regulates Nt17 by associating with the C-terminal portion of the 
tract, part of which may be helical in amyloid fibrils,4, 14, 15 thus, not allowing 
helical formation of a full, extended α-helix ranging from A2 to E12. This would 
explain the inherent lack of helicity in Nt17-Qn-Pm and htt exon 1 monomeric 
structures measured by spectroscopy,4 while Nt17 alone in its monomeric and 
multimeric form is free to form extended α-helices. This could also explain the 
acceleration of aggregation observed when Nt17 is associated to extended polyQ 
regions without the proline-rich domain;9, 10 the proline domain is not present to 
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regulate Nt17 helical formation, thus allowing Nt17 to drive aggregation through 
helical association.  
 The second similarity in the two structures are the involvement, or relative 
proximity, of S13 and S16 to the polyP tract. CYP-labeled Phosphomimetic and 
hyperphosphorylated htt exon 1, with Qn = 9 showed a dramatic reduction in 
FRET intensity compared with wild type htt exon 1. In the gas-phase structures 
reported in the current work, phosphorylation of S13 and S16 could feasibly 
disrupt interaction with the polyP sequence. In previous work, htt exon 1 with S to 
D mutation showed a decrease in aggregation kinetics and decreased aggregate 
stability. Phosphorylation of these S residues both reduces polyP interaction in 
native htt exon 1, and suppresses aggregation kinetics.7, 16 While these 
mutations were not probed in this study, it is worth pointing out a similarity 
between the gas phase structures reported here and the results observed in 
other work. 
 
4.3.4 Incubation with polyP reduces htt exon 1 fibril formation.  
 Figure 6 shows representative AFM images taken at 24 hours after GST 
cleavage. Panel A depicts htt exon 1, while panels B and C show htt exon 1 co-
incubated with Nt17 and polyP, respectively (see Experimental Procedures for 
incubation conditions). Htt exon 1 formed characteristic amyloid fibrils. The 
structures shown in panel A are nearly identical in height and length to those 
reported elsewhere using the same protein. When co-incubated with Nt17, htt 
exon 1 still forms amyloid fibrils. Previous experiments that reported co-
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incubation of htt exon 1 peptides with Nt17 showed similar morphologies to those 
reported in Figure 6B at the 24 hour time point. In their study, Mishra et al. report 
more stable oligomer structures when htt exon 1 is co-incubated with Nt17 at 
shorter time points.5  Figure 6C shows a representative AFM image taken at t = 
24 hours of htt exon 1 co-incubated with the polyP peptide. A striking difference 
is observed relative to Figure 6A; significantly fewer extended fibrillar species are 
apparent in the sample co-incubated with polyP. Short, amorphous, possibly 
oligomeric species are observed, much like Mishra et al. observe for their Nt17-
htt exon 1 co-incubation at shorter time points.5 It would appear, then, that the 
polyP peptide has an amyloidogenic inhibitory effect in a model protein system.   
 
 
Figure 4.6. Representative AFM images. Images of htt exon 1 (51Q, t = 24 hrs.) 
deposited on a mica surface. A htt exon 1. B htt exon 1 co-incubated with Nt17. C htt 
exon 1 incubated with polyP. 
 
 Several interpretations of this observed polyP inhibitory effect could be 
plausible. First, the polyP peptide could interact with the polyQ domain, which 
could stabilize the random nature of polyQ and prohibit the transition to β-sheet. 
Additionally, interaction at multiple sites in the polyQ domain could increase the 
distance between adjacent polyQ chains. PolyQ segments could transiently 
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sample PPII conformations,20, 38 which would be amenable for intermolecular 
interaction with the polyP peptide in its PPII state. Previous studies have shown 
inhibition of short polyQ fragments in a PPII conformation by N-methylated short 
peptide sequences.39 Since the IMS-MS data reported in this study did not take 
into account a polyQ tract, no definitive comment can be made on the inhibition 
of polyQ aggregation by direct intermolecular interaction with polyP. Although the 
addition of the polyP peptide could interact with the proline-rich region in htt exon 
1 and stabilize the PPII character further, in the IMS-MS experiments we do not 
observe a polyP homomultimer of any kind, which suggests that this interaction 
could be unlikely. Still, because the full proline-rich region was not sampled in 
IMS-MS, a C-terminal interaction responsible for aggregation suppression cannot 
be ruled out. A comment can be made, however, on inhibition of htt exon 1 
aggregation through a process mediated by Nt17. Like previous studies that have 
shown aggregation inhibition through targeting Nt17 with small peptides,5 and 
molecular chaperones40, 41 polyP could associate with Nt17 at a critical interface 
causing stabilization of an oligomeric state by not allowing further polyQ 
association. Interstitial insertion of polyP into the N-terminal htt exon 1 helical 
bundles could act in the same manner as Nt17, increasing distance between 
polyQ chains and thus, increasing the energy required to form β-sheet rich 
aggregates. Alternatively, the polyP region could partially shut down Nt17 helix 
formation in disease-length htt exon 1 constructs, thus decreasing kinetics of fibril 
formation, though still proceeding through an oligomeric intermediate. While the 
polyQ-associated polyP region would no longer be in proximity of Nt17 for 
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regulation, free polyP peptide can insert and act to regulate Nt17 in the same 
manner. In any case, incubation of htt exon 1 with a polyP peptide reduced fibril 
formation. Future studies are necessary to fully characterize this interaction. 
 
4.3.5 Interpretation of structural findings.  
 This study reports, for the first time, multiple conformations of a Nt17-
polyP complex that could have implications in Huntington’s disease-related 
amyloid formation. Previous work suggests that the C-terminal polyP region acts 
as a stabilizer of Nt17 for short polyQ lengths; however, as polyQ length 
increases the resulting rigidity increases the distance between the Nt17 tract and 
the polyP tract. The increased distance allows Nt17 to participate in 
intermolecular associations with other Nt17 tracts, or perhaps the associated 
polyQ, to initiate fibril formation. This is supported by the data in Figure 4.2, 
where increased complexation energy is suggested for the Nt17 homodimer 
relative to the Nt17-polyP heterodimer; the increased energy supports the claim 
that Nt17 has a high self-affinity, and thus can act to nucleate aggregation. 
Additionally, no decrease in Nt17 homomultimer is observed upon addition of the 
polyP peptide, which, again indicates that the Nt17 helix-helix interaction 
overcomes the Nt17-polyP hetrodimerization. This could have implications for the 
native function of Nt17 as a nuclear export signal and modification target,27, 42, 43 
as complexation with polyP near an active site would act to regulate kinase 
activity that leads to nuclear export signaling, especially if key hydrophilic 
residues are buried in the complex. 
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 The gas-phase structures reported in Figure 4.5 provide a clearer picture 
of what potential Nt17-polyP complexes may resemble. While these are gas-
phase conformations, it should be noted that the method used here has been 
used in previous experiments to accurately predict condensed phase structure 
and pinpoint protein heterogeneity.32, 35, 44 Along with these studies, the work may 
indicate that condensed phase Nt17 structure could range anywhere from mostly 
disordered4 to fully extended.45 Indeed, previous IMS-MS experiments report that 
Nt17 could consist of a heterogenous mix of partial helix and extended helix in 
the gas phase (see Chapter 3). Extended Nt17 homodimers could consist of two 
elongated antiparallel helices. These data lead to the hypothesis that Nt17 only 
adopts a fully extended helical structure when involved in a complex. In both the 
compact and elongated structures shown in Figure 4.5, however, Nt17 adopts a 
mostly random coil motif. The differential deuterium uptake by conformation is 
then explained by the involvement of hydrophilic residues in stabilizing the 
complex and the relative proximity to charge sites, and to a much lesser extent, 
the presence of secondary structure. Based on these data, it could be 
hypothesized that C-terminal Nt17 complexation with the polyP helix stabilizes 
the random coil nature of Nt17, thus preventing a transition to the extended α-
helix, as observed in amyloid fibrils14, 15 and hypothesized for an extended 
homodimer. In addition to inhibition through insertion, the co-incubated polyP 
could possibly act to disallow the helical transition in Nt17, thus promoting 
formation of more amorphous aggregates, as shown in Figure 4.6, or entirely 
abolishing aggregation. A caveat to this work as with the work presented in 
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Chapter 3, is the lack of a polyQ sequence. The polyQ linker would restrict the 
freedom of the polyP and Nt17 domains and may impart structure into these 
regions; however, solid-state NMR results indicate that in a mature fibril, the 
polyP PPII helix abruptly stops immediately before the polyQ domain and the β-
sheet character of the polyQ region only extends to the last two residues of 
Nt17.15 
 The work described in this chapter highlights potential interactions 
between Nt17 and the polyP regions on htt exon 1. PolyP could serve as a 
regulator of Nt17 in non-pathogenic htt exon 1. Two Nt17-polyP heterodimer 
complexes were observed in the gas phase, both of which are energetically 
weaker than an Nt17 homodimer. A gas-phase deuterium exchange experiment 
shows differential uptake between the conformations, which suggested greater 
availability of charge sites in Nt17, which could have implication in complex 
orientation, presence of secondary structure, or both. Simulated annealing 
experiments reveal a mostly unstructured, C-terminal Nt17 region in the gas 
phase when complexed to the all-trans polyP peptide, which is in stark contrast 
to gas-phase orientation of the Nt17 homodimeric complex, which, in its most 
elongated state, is composed of two extended α-helices arranged antiparallel to 
each other (see Chapter 3). Incubation of disease-length htt exon 1 with the 
polyP tract led to a reduction in fibril formation relative to control htt exon 1, which 
suggests that polyP has an inhibitory effect on htt exon 1. Together, the data 
described in this work suggest that the polyP region inhibits formation of the 
amphipathic α-helix by Nt17, thus reducing the ability to participate in 
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energetically favorable helix-helix interactions. This work has laid the groundwork 
for future studies seeking not just blockage of a critical residue, but perhaps 
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5. Outlook: Physiologically relevant post-translational 
modifications of Nt17 and regulation through complexation 
 
 The work described in this document begins with identification of critical 
residues in htt exon 1, moves into modification of residues and measurements of 
gas phase structure, then finally, into Nt17-regulating effects of an endogenous 
sequence. What has not been discussed, however, is the effect of physiologically 
relevant post-translational modification. The work-in-progress described here 
aims to study acetylation and phosphorylation of Nt17 in the context of secondary 
structure, aggregation suppression, and other physiological properties, such as 
lipid binding. These studies will serve to supplement the works described in this 
document, and provide additional critical insight into mechanisms of Nt17-
mediated aggregation.  
 
5.1 Work in Progress: Acetlyation of Nt17Q35P10KK by sulfo-NHSA 
5.1.1 Acetylation of Nt17 suppresses aggregate formation and alters aggregation 
kinetics. 
 Nt17’s ability to interact with substrates and other Nt17 tracts appears to 
be predicated on the ability of the sequence to form an amphipathic α-helix. As 
shown in this work, and by others,1-3 structural perturbation by side chain 
modification at critical interfaces can partially absolve Nt17-mediated htt exon 1 
multimer formation. The modifications in this work, however, are not physiological 
in nature. Thus, a thorough characterization of small, physiologically-relevant 
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post-translational modifications is necessary. In Chapter 2, the N-terminal htt 
sequence was probed using HDX- and DHX-MS.  
This study laid the groundwork 
for future investigations of 
lysine modifications by 
pinpointing critical lysine 
residues in Nt17 that may be 
solvent-protected when 
incorporated in an aggregate. 
Lysine residues are targets for 
PTM’s in vivo, thus, a 
characterization of the effects 
of these PTM’s on aggregation 
kinetics and morphologies is a 
logical next step.. 
Nt17, in addition to its 
properties in driving 
aggregation, can undergo 
numerous PTM’s, such as 
SUMOylation,4 
phosphorylation,5, 6 and acetylation.7 These PTM’s can have significant effect on 
aggregation kinetics and morphologies. Preliminary data has been acquired that 
demonstrated the effect of acetylation on β  sheet formation (Figure 5.1).  
 
Figure 5.1. Acetylation of Nt17Q35P10KK reduces 
β-sheet formation. A) Percent modification of each 
lysine residue in Nt17as a function of label 
concentration (mol:mol). B) ThT curves by label 
concentration. Increased labeling reduces β-sheet 
formation. 
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 Lysine residues were modified with sulfo-N-hydroxysuccinimide (NHSA), 
which replaces primary amine groups with an acetyl group. Acetylation was 
chosen because it removes charge from the lysine side chain, thus preventing 
salt bridging to negatively charged residues. Modification by sulfo-NHSA of lysine 
ε-amino groups has been used as a structural probe in previous work.8, 9 In those 
studies, the label was added as a probe to determine sites of surface availability. 
In the present work, however, NHSA is used to modify lysine residues in the 
monomeric state and determine implications on downstream aggregation. 
Labeling was performed with the molar ratios of NHSA to peptide of 1:1, 2:1, or 
3:1. Controls were performed with no label added to the peptide. Percent 
modification of the three lysine residues in Nt17 was determined in a label 
concentration-dependent manner. The percent modification of the N-terminus 
was not considered because it is pre-acetylated in the synthetic peptide. Of the 
three lysine residues in Nt17, K9 is most readily acetylated, while K15 does not 
appear to appreciably label relative to the other lysine residues. This result is 
consistent with previous findings that state K9 is an acetylation site in full-length 
huntingtin, which targets degradation to the proteasome.10, 11  K6 and K9 are 
labeled appreciably more than K15 at the 1x concentration. At the 2x 
concentration of label, acetylation of K9 is nearly saturated, while K6 and K15 
remain at 40 and 20% modified, respectively. Finally, at 3x label:peptide 
concentration, modification at K6 did not appreciably increase from 2x, while K9 
and K15 modification is only increased slightly.  
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   Aggregation at each label:peptide ratio was monitored by ThT 
fluorescence (Figure 5.1B).  While the lag phase of aggregation was not 
appreciably altered with exposure to 1x label, a decrease in fluorescence 
magnitude, and thus β-sheet formation, was observed. K6 and K9 were most 
readily acetylated, which is in good agreement with the data presented in 
Chapters 2 and 3. At the 2x label:peptide ratio, the increase in lysine modification 
results in an elongation of the aggregation lag phase, as well as another 
decrease in β-sheet formation. A significant increase in percent label from 1x to 
2x is observed for K9 and K15. Finally, at the 3x concentration, β-sheet formation 
is reduced by 50%, relative to the 1x concentration at the 350 minute time point, 
which correlates to the statistically significant labeling increase from 1x to 3x for 
all lysine residues. Since K9 completely back-exchanges in deuterium exchange 
experiments, the large drop in β-sheet content is most likely attributed to labeling 
at K6 and K15. Still, modification at K9 increases significantly for all three 
label:peptide ratios, so its role cannot be completely disregarded. Further study is 
required to discern the actual role of each lysine residue. The most logical probe 
is a chemical point mutation that simulates acetylation (K to Q).   
 
5.2 Work in Progress: K to Q mutations in Nt17 
5.2.1 K to Q mutations alter Nt17 secondary structure.  
 A significant portion of the work described in this work focuses on 
structural ramifications of altering native Nt17 at critical lysine residues.  Figure 
5.2 shows a mass spectrum (A) and IMS-MS distributions of a doubly charged  
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K6Q Nt17 monomer (B) and dimer 
(C). Peptides were prepared, and 
IMS-MS experiments were 
performed, in the same manner as 
outlined in Chapters 3 and 4. A 
decrease in overall multimer is 
observed; however, dimer and 
trimer species are not completely 
abolished. Doubly charged 
monomer dominates the mass 
spectrum, which is to be expected 
based on experiments with this 
peptide  
discussed in Chapters 3 and 4. It 
appears that monomer structure is 
affected by the K6Q mutation. The 
same collapsed monomer feature 
(Figure 5.2B, 11.6 ms) is observed 
in this distribution, as was in others 
presented in previous chapters. 
Interestingly, there appears to be a 
higher abundance of a more 
collapsed structure (8.6 ms). This could be due to a complete loss of structure 
 
Figure 5.2. MS and IMS-MS distributions of 
Nt17 K6Q point mutations. A) Full mass 
spectrum of K6Q Nt17. Ions of interest are 
labeled. B) IMS-MS distribution of the doubly 
charged monomer. C) IMS-MS distribution of 
the triply charged dimer. 
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from the helical state, though this has not been confirmed by MDS results. A 
more elongated conformation is also evident, which, strikingly, matches the drift 
time for the partially collapsed intermediate observed in Chapter 3. While 
acetylation is not the same as carbethoxylation, substitution of the primary amine 
group on K6 with a more nonpolar moiety could yield the same results as 
carbethoxylation, though not as dramatic.  
 The effect of acetylation could also be explored in the context of lipid 
binding. Nt17 and the polyP tract are required in the oligomerization of htt exon 1 
on lipid substrates,12 thus interactions of Nt17 and lipid substrates could be of 
great interest in HD remediation. At first, simple colorimetric assays, such as a 
polydiacetlyene (PDA) assay13, 14 could be used to determine Nt17 and point-
mutated Nt17 lipid binding propensity. Experiments could then evolve into AFM 
experiments on a lipid bilayer that contains point-mutated htt exon 1 to determine 
extent of bilayer disruption. Finally, IMS-MS could supplement these experiments 
with gas-phase measurements and calculations of Nt17 structure featuring 
various point mutations. 
 
5.3 Future Direction: Targeting Nt17 with other proteins  
 Physiologically endogenous proteins could also have a therapeutic effect 
in HD remediation. Hsc70 binds to the amino terminus of htt exon 1 and prevents 
aggregation by preventing helical homodimerization.15 To date, no work has 
focused on Hsc40/70 interactions with pre-aggregated species. If the N-terminal 
region is indeed solvent-exposed in the early oligomeric or aggregated state, 
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then theoretically the Hsc70 complex could function like the polyP-recognizing 
antibody, 3B5H10. 3B5H10 served to disaggregate htt exon 1 aggregates by 
taking advantage of the on-off equilibrium between monomer and fibril.16 The 
antibody sequestered soluble monomer from the amyloid fibril through 
association of the polyP region, and eventually, dissolved amyloid fibrils. The 
Hsc70 machine could take advantage of the same on/off equilibrium to recognize 
and sequester htt exon 1 through the Nt17 region. Intrabodies specific for Nt1717, 
18 could be used in control experiments to compare morphological details 
between something that is specific for Nt17 and something that is less specific, in 
this case, the Hsc70 complex. Presence of secondary structure and residue-
specific information could be obtained through HDX and DHX experiments, much 
like those performed in Chapter 2. This would only be a confirmatory study for 
the Nt17 intrabody controls; Nt17 adopts a helical structure in the intrabody 
complex.17 Whether Hsc70 acts on the unstructured or structured Nt17 remains 
to be shown, and could be demonstrated by the techniques outlined in Chapter 2. 
 
5.4 Concluding remarks 
 The works contained in this document are meant to provide a greater 
structural insight to HD-related aggregates, pinpoint critical residues and 
interfaces in early-stage aggregates, and develop a model for intrinsic, and 
possibly extrinsic, stabilization of a peptide sequence that is implicated in 
oligomer architecture. Additionally, these works detail the analytical utility of IMS-
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MS and gas-phase structural measurements in the study of relevant problems in 
 
Figure 5.3. Schematic of Nt17-mediated htt exon 1 aggregation for modified and 
regulated Nt17. Nt17 association leading to aggregation is regulated by post-
translational modification and/or the presence of an external regulator. Red: Nt17; black: 
polyQ; blue: polyP. A) Normal, monomeric htt exon 1 with a non-disease-length polyQ. 
PolyP regulates Nt17 by not allowing helical transition. B) PolyQ gains rigidity at disease 
length, increasing distance from Nt17, thus allowing helical transition and association, to 
eventually form amyloid fibrils. C) A PTM in or near the helical sequence destabilizes 
helical character and moderates Nt17 association. D) Presence of an external regulator, 
such as polyP, prevents helical formation. In cases C and D, amyloid fibrils still form, just 
not to the same extent as unmodified/unregulated Nt17. Additionally, it should be noted 
that this is only one part of an overall aggregation mechanism, as the polyQ region can 
still self-associate into amyloid fibrils. 
 
 
biophysical chemistry. IMS-MS, when coupled to secondary techniques like 
MDS, offers the benefit of discrete structural characterization of analytes that 
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sample a heterogeneous mix of secondary, tertiary, and quaternary 
arrangements. HDX and DHX supplement these studies and show, by deuterium 
retention in the condensed phase or deuterium incorporation in the gas phase, 
sites where labile heteroatoms are protected through H-bond interactions or 
solvation. The condensed-phase experiments verified that Nt17 is solvent-
exposed and mostly structured when incorporated in an aggregate. Additionally, 
the increased protection on K6 led to the hypothesis that the availability of lysine 
residues may be critical determinants in Nt17-mediated htt exon 1 aggregation. 
Subsequent ion mobility-mass spectrometry studies revealed structural 
heterogeneity in Nt17 that persists into the multimeric form; however, upon 
modification at two sites, one of which is K6, structure is perturbed and 
multimerization is drastically decreased. Finally, co-incubation of Nt17 with a 
polyP sequence drastically decreased helical content in the gas phase, and 
perhaps in a physiologically relevant construct, providing a structural framework 
for intrinsic htt exon 1 stabilization.  
 It is with this that these studies have laid the groundwork for future IMS-
MS studies to glean insight toward protein structure, with the eventual aim of 
ameliorating HD pathology. The next critical step is to further elucidate the effects 
of physiological post-translational modification in the condensed phase, the gas 
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